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Abstract 
Apoptosis is now becoming recognized as an important event in the 
development and function of the reproductive system. The present study is aimed at 
determining the role of the nitric oxide (NO), soluble guanylyl cyclase 
(sGC)/cGMP/protein kinase G (PKG) signaling pathway in the regulation of apoptosis 
in two types of female reproductive cells, uterine epithelial cells and ovarian cancer 
cells. The effects on apoptosis of a NO donor, sGC activators and inhibitors, and PKG 
activators and inhibitors were determined in cultures of a rabbit immortalized uterine 
epithelial cell line, HRE-H9 cell, and a human ovarian epithelial cancer cell line, 
A2780s cells. The effects of the NO donor were also determined in primary cultures 
of mouse uterine epithelial cells. A new quantitative ultrasensitive technique using 
capillary electrophoresis with laser-induced fluorescent detector (CE-LIF) was used in 
some of the experiments as a novel way to accurately measure the levels of apoptotic 
DNA fragmentation (an index of apoptosis). 
The NO donor sodium nitropmsside (SNP) concentration-dependently induced 
apoptosis in HRE-H9 cells and primary mouse uterine epithelial cells, indicating that 
these cells are susceptible to the toxic/pro-apoptotic effects of SNP at higher 
concentrations (0.5-1.0 mM). Two sGC inhibitors, NS2028 and ODQ were used to 
inhibit basal sGC activity and both were found to increase apoptotic DNA 
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fragmentation in HRE-H9 cells. The data suggest that the basal activity of sGC and 
basal cGMP levels may be important for preventing spontaneous apoptosis. A cell 
permeable cGMP analogue, 8-bromo-cGMP, which directly activates PKG, prevented 
the ODQ-induced apoptosis in HRE-H9 cells, suggesting that a lowering of basal 
PKG activity resulting from the sGC inhibition may have been responsible for the 
induction of apoptosis. Direct inhibition of PKG activity with KT5823 increased 
apoptotic DNA fragmentation in HRE-H9 cells. These data suggested that basal 
cGMP/PKG may be necessary to prevent spontaneous development of apoptosis in 
these uterine epithelial cells. 
Increasing the activity of sGC above basal levels has been shown to exert 
either anti-apoptotic or pro-apoptotic effects, depending on the type of cells and the 
experimental conditions. The present study determined if activators of sGC and PKG 
affect serum-deprivation-induced apoptosis in HRE-H9 cells, using a direct, non-NO 
activator of sGC, YC-1, and two cell-permeable direct activators of PKG, 
8-pCPT-cGMP and Sp-8-Br-PET-cGMPS. YC-1, 8-pCPT-cGMP and 
Sp-8-Br-PET-cGMPS all enhanced the apoptotic DNA fragmentation induced by 
serum deprivation, measured by CE-LIF. 
The present studies thus demonstrated that under basal unstimulated 
conditions, basal activities of sGC and PKG were shown to be protective to the 
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uterine epithelial cells. However, when the sGC and PKG activities were stimulated, 
elevating cGMP levels and PKG activity above the basal levels, the effects of the 
sGC/cGMP/PKG pathway seems to switch from anti-apoptotic to pro-apoptotic. 
XIAP, one of the proteins in the inhibitor of apoptosis (lAPs) family, has been 
demonstrated to suppress apoptosis in human ovarian epithelial cancer cells. The 
present study hypothesized that the basal sGC activity in human ovarian epithelial 
cancer cells exerts anti-apoptotic effects. These effects may involve the regulation of 
XIAP expression. The sGC inhibitor ODQ was used to determine the effects of basal 
sGC activity on the levels of apoptosis and XIAP expression in a cisplatin-sensitive 
ovarian cancer cells line, A2780s cells. Exposure of A2780s cell to ODQ caused a 
concentration-dependent increase in apoptosis as measured by Hoechst nuclear 
staining. The increase in apoptosis was accompanied by a significant decrease in 
XIAP protein content. Overexpression of XIAP caused a concentration-dependent 
protection of the A2780s cells against ODQ-induced apoptosis. The data suggested 
that cGMP at basal levels may be involved in preventing spontaneous entry into a 
pro-apoptotic pathway in the ovarian cancer cells and that down-regulation of XIAP 
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Chapter 1: Introduction 
1.1 Major objective and long-term significance 
The major objective of this research project was to investigate the functional roles 
of the nitric oxide (NO)/cGMP/protein kinase G (PKG) signaling pathway in the regulation 
of apoptosis and XIAP protein content in cells of the female reproductive system. It is 
hoped that the findings of this study will provide a better understanding of the fundamental 
mechanisms of signal tranduction that regulate apoptosis. It is also hoped that the 
improved understanding of apoptosis can lead to the development of new and better drugs 
for treating diseases and condition caused by dysregulation of apoptosis, including cancer, 
dysmenorrhea, endometriosis and infertility. 
1.2 Biological significance of apoptosis 
Apoptosis, also called programmed cell death, has gained widespread attention in 
recent years due to its newly discovered role in a variety of physiological and pathological 
processes (Thompson, 1995; Jacobson et al., 1997). Apoptosis is an active physiological 
mode of cell death, in which the cells execute a program of their own demise and 
subsequent disposal. This apoptotic pathway is apparently shared by all multi-cellular 
organisms and is critical for the successful development of multiple tissues during 
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embryonic development and the maintenance of normal tissue homeostasis after 
development. 
Cells have the ability to self-destruct by activation of an intrinsic cellular suicide 
program when they are no longer needed or become damaged irreparably after exposure to 
stressful stimuli or infectious agents, or when they no longer receive signals from specific 
survival factors (Kerr et al., 1972). Therefore, apoptosis is important to many physiologic 
processes such as cell selection in development and immunologic responses (Pospisil et al., 
1995), in the control of organ size in maturation and regeneration (Raff, 1996) and in 
normal cell turnover throughout the organism (Thompson, 1995). The regulation of 
apoptosis is thus critical for many processes, including development, the defense against 
pathogens and the prevention of proliferation of transformed cells. 
Dysregulation of apoptosis may underlie the etiology of several diseases. It is 
known that apoptosis plays an important role in the maintenance of physiological 
homeostasis in response to stimuli that indicate that a cell is potentially harmful or 
abnormal (Steller, 1995; Thompson, 1995). When the apoptosis machinery fails, abnormal 
cells can survive, and unopposed tissue growth, as in the case of cancer, can result. Failure 
of dividing cells to initiate apoptosis in response to DNA damage has been implicated in 
the development and progression of cancer and leukemia. Thus, carcinomas may be caused 
or promoted in part by factors inhibiting cell death. On the other hand, increased levels of 
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apoptosis may be involved in other diseaseses, such as neurodegenerative diseases (Kure et 
aL, 1991). 
1.3 Importance of apoptosis in the study of female reproduction system 
Apoptosis is now recognized as an important event in the development and 
function of the reproductive system (Gosden and Spear, 1997). Apoptosis is important for 
the normal function of both uterine epithelial cell and ovarian epithelial cell in the female 
reproductive system. (For more detail, see literature review) 
1.4 Specific aims of the present project 
The specific aims of this project were focused on resolving the following questions: 
(1) Is NO a pro-apoptotic agent in uterine epithelial cells? Can the levels of apoptotic 
DNA fragmentation induced by NO be accurately quantified? 
Data from two recent studies have suggested that NO may have toxic effects in 
uterine epithelial cells, leading to increased apoptosis. First, isolated slices of human 
endometrial tissue show increased apoptosis (assessed by TUNEL staining) when 
incubated in vitro with L-arginine, the precursor of NO biosynthesis (Castro et al., 2002). 
Second, a human endometrial carcinoma cell line (RL95-2 cells), when exposed to sodium 
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nitropmsside (SNP), a NO donor, showed decreased cell survival, assessed by the MTT 
technique, and increased caspase-3 activity, indicator of apoptosis (Li et al., 2001b). These 
finding suggested that NO is pro-apoptotic to uterine epitheial cells. However, to our 
knowledge, there have been no previous reports providing an accurate measure of 
apoptotic DNA fragmentation to quantify the pro-apoptotic effects of NO in uterine 
epithelial cells. The purpose of the present study was to accurately quantify the effects of 
the NO donor SNP on apoptotic DNA fragmentation in uterine epithelial cells, using both a 
rabbit immortalized epithelial cell line (HRE-H9 cells) and primary cultures of mouse 
uterine epithelial cells and two techniques for assessing DNA fragmentation, agarose gel 
electrophoresis and the new quantitative capillary electrophoresis with laser-induced 
fluorescence (CE-LIF). 
(2) Are basal levels of cGMP and PKG activity exerting anti-apoptotic effects in 
uterine epithelial cells? 
NO exerts anti-apoptotic effects in certain cells, either through mechanisms 
involving activation of soluble guanylate cyclase (sGC) and subsequent elevation ofcGMP 
levels or, in some cells, through mechanisms independent of sGC (Kim et al., 1997; Kolb, 
2000; Fiscus, 2002; Fiscus et al., 2002). Endogenous NO synthesis or exposure to low 
levels of NO donors has now been shown to inhibit apoptosis in a number of different 
kinds of cells, including B lymphocytes (Mannick et al., 1994; Genaro et al., 1995)， 
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eosinophils (Beauvais et al., 1995), ovarian follicles (Chun et al., 1995), endothelial cells 
(Dimmeler et a l , 1997) and rat cerebellar granule cells and cortical cells (Pantazis et al., 
1998; Femandez-Tome et a l , 1999). In some of these cells, the anti-apoptotic actions of 
NO were shown to be dependent on the cGMP elevations (Beauvais et al., 1995; Chun et 
al., 1995; Genaro et al., 1995), while in other cells, the anti-apoptotic mechanism of NO 
was independent of cGMP (Mannick et al., 1994). 
Previously data from the laboratory of Professor Fiscus had shown that two 
natriuretic peptides, atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), 
which activate particulate guanylyl cyclase (pGC) and cause prolonged elevations of 
cGMP levels, are potent and effective inhibitors of apoptotic cell death caused by semm-
deprivation-induced stress in PC 12 cells, resulting in a significant prolongation of cell 
survival (Fiscus et a l , 2001b). Furthermore, 8-Br-cGMP, a cell-permeable analog of 
C G M P that directly activates P K G , was also found to inhibit apoptosis in stressed P C 12 
cells. Thus, cGMP and PKG appeared to be intimately involved in the prevention of 
apoptosis and the prolongation of cell survival, at least in certain types of cells, like PC 12 
cells. Many other neural cells have also been found to possess a similar anti-apoptotic/pro-
survival pathway involving the cGMP/PKG signaling pathway (for Reviews, see Fiscus, 
2002; Fiscus et al., 2002). Furthermore, in some neural cells, such as NlE-115 and 
NG108-15 cells, even the basal levels of cGMP and basal activity of PKG appear to be 
sufficient to cause anti-apoptotic effects, protecting these cells against a spontaneous 
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development of apoptosis (Yuen and Fiscus, 2001; Fiscus, 2002). The present study was 
designed to determine if basal cGMP levels and basal PKG activity are involved in the 
control of apoptosis in uterine epithelial cells, using an immortalized cell line, the HRE-H9 
cells. 
(3) What are the effects on apoptosis of elevating cGMP levels and PKG activity in 
uterine epithelial cells? 
The effects of sGC on the survival of mammalian cells appear to be different in 
different cell types and different experimental conditions. For example, activation of sGC 
has been shown to exert pro-apoptotic effects in some types of cells, including 
cardiomyocytes (Taimor et al., 2000), colon tumor cells (Thompson et al , 2000) and 
vascular smooth muscle cells (Pollman et al., 1996). However, there are also reports 
showing protective effects of sGC on the survival of other types of cells, such as neural 
cells (Garthwaithe and Garthwaithe, 1988; Garthwaite et al., 1995; Estevez et al., 1998; 
Thippeswamy and Morris, 1997; Fiscus, 2002; Fiscus et al., 2002), leukemia cells 
(Flamigni et al., 2001) and liver cells (Li et al., 2000). In the present study, we determined 
the effects of a direct, NO-independent sGC activator, YC-1, on the apoptosis induced by 
serum deprivation in HRE-H9 cells. NO was not used as an activator of sGC in the present 
study because it is known to activate a number of toxic/pro-apoptotic pathways that are 
independent of the sGC/cGMP pathway (Fiscus, 2002; Fiscus et al., 2002). The effects of 
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three cGMP analogues, 8-Br-cGMP, 8-pCPT-cGMP, Sp-8-Bromo-PET-cGMPS, all of 
which are cell-permeable, direct activators of PKG, were also determined on the induction 
of apoptosis in HRE-H9 cells. 
(4) What are the effects of basal sGC activity on the regulation of apoptosis and the 
expression of XIAP in ovarian cancer cells? 
Basal activities of sGC and a downstream target protein in the cGMP signaling 
pathway, protein kinase G (PKG), appear to be important for the survival of uterine 
epithelial cells (Chan and Fiscus, 2002) and several neural cell lines (Yuen and Fiscus, 
2001; Fiscus, 2002). There may be a similar involvement of basal sGC and PKG activities 
in regulating the survival of ovarian cancer cells. In ovarian cancer cells, the anti-apoptosis 
protein XIAP is known to play an important role in preventing apoptosis, thus prolonging 
the survival. For example, infection of cisplatin-sensitive ovarian cancer cells with 
adenoviral sense XIAP complementary DNA resulted in overexpression of XIAP and 
markedly attenuated the ability of cisplatin to induce apoptosis (Li et al., 2001a). A 
working hypothesis of the present study was that at least part of the anti-apoptotic effects 
of the sGC/cGMP signaling pathway may involve the regulation of XIAP expression. The 
present study determined the effects of the sGC inhibitor ODQ on the levels of apoptosis 
and XIAP expression in a cisplatin-sensitive ovarian cancer cell line, the A20780s cells. 
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1.5 Experimental Approaches 
(1) Capillary Electrophoresis with Laser-Induced Fluorescence Detector (CE-LIF) 
The present study utilized CE-LIF to determine the levels of apoptosis in both 
immortalized rabbit uterine epithelial cells and primary cultures of mouse uterine epithelial 
cells. Intemucleosomal fragmentation of DNA is a hallmark of apoptosis in many cells 
(Compton, 1992). Unfortunately, the conventional technique for measuring apoptotic DNA 
fragmentation, i.e. DNA laddering by agarose gel electrophoresis, is a relatively insensitive 
method that typically requires 1-10 million cells per sample for the detection of apoptosis 
(Fiscus, 2002; Fiscus et al., 2002). Furthermore, DNA laddering on agarose gels is not 
quantitative, making it difficult to objectively analyze the effects of pro- and anti-apoptotic 
agents. 
Recently, our laboratory has developed an ultrasensitive quantitative technique for 
quantifying apoptotic DNA fragmenation in neural cells (Fiscus et al., 2001b; Fiscus, 2002; 
Fiscus et al., 2002), uterine epithelial cells (Fiscus et al., 2001a) and epididymal epithelial 
cells (Cheuk et al” 2002) using capillary electrophoresis (CE) coupled with the new, 
ultrasensitive laser-induced fluorescence detector (LIF). This new CE-LIF technology 
provides a more than 1,000-fold improvement in the sensitivity of measuring DNA 
fragmentation, as compared to the conventional agarose gel technique. Furthermore, both 
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internal and external DNA standards as well as computer analysis of CE-LIF 
electropherograms are used to accurately quantify the levels of apoptotic DNA 
fragmentation caused by proapoptotic agents as well as the percentage of inhibition of 
apoptosis caused by anti-apoptotic agents. 
This technology allows, for the first time, accurate measurement of apoptotic DNA 
fragmentation in experiments using limited, small numbers of cells, such as primary 
cultures or extremely small punch biopsies. Besides, CE-LIF has the advantage that the 
resulting data can be analyzed by objective methods using modem statistical techniques. 
Furthermore, because of the exquisite sensitivity of the CE-LIF technology, which requires 
fewer cells for analysis of apoptotic DNA fragmentation, larger numbers of treatment 
conditions and replications of these conditions can be tested. 
(2) Nuclear Staining (Hoechst Staining) 
The morphology of apoptosis is strikingly similar in different cell types. As 
recognized by electron microscopy, the nuclear chromatin aggregates into uniformly dense 
masses, which abut on the nuclear membrane as the cytoplasm begins to compact. These 
changes are followed by breaking up of the nucleus into discrete fragments together with 
fragmentation of the cell (Wyllie et al., 1980). In our study, apoptosis of human ovarian 
epithelial cancer cells, A2780s cells, was quantitatively measured by nuclear staining. 
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Apoptotic nuclei with condensed chromatin was characterized and quantified by staining 
with the DNA-specific dye Hoechst 33248. Nuclear staining was observed and 
photographed using a Zeiss fluorescence microscope (magnification 400X). Cells with 
typical apoptotic nuclear morphology (nuclear shrinkage, condensation, and fragmentation) 
were identified and counted, using randomly selected fields on numbered photographic 
slides to avoid bias. A minimum of 600 cells per treatment was counted in each treatment. 
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Chapter 2 Materials and Methods 
2.1 General experimental methods 
2.1.1 Culture of cells 
2.1.1.1 Culture of rabbit immortalized uterine epithelial cells 
The HRE-H9 cells were grown in Dulbecco's Modified Eagle Medium (DMEM) 
with phenol red containing 4% heat-inactivated fetal bovine serum, 100 U/ml penicillin 
and 100 \ig/m\ streptomycin, in the presence of 5% CO2 at 3TC, which was a slight 
modification of the method of Wing and coworkers (Wing et al., 1998). During passaging, 
the cells were washed with Hank's Balanced Salt Solution (HBSS, without phenol red) and 
harvested by trypsinzation using trypsin. The cells were counted using a haemocytometer. 
In all experiments, the cells were used between passage 20 and 45. For preparation 
of experiments using only CE-LIF to determine DNA fragmentation, cells were seeded in 
medium supplemented with 4% serum in 6-well culture plates at a density of 1 million 
cells per well. After 24 h, the medium was aspirated and replaced by medium of the 
different conditions indicated in the results. For the experiments of overcrowding-induced 
apoptosis, in which both CE-LIF and agarose gels were used to determine DNA 
fragmentation, cells were plated into 100 mm culture dishes at a density of 5 million cells 
per dish. Cells were allowed to grow in the presence of 5% CO2 at 37°C for 24, 36, 48, 60 
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and 72 h in the same medium as above. For the NO-induced apoptosis in HRE-H9 cells, 
using both CE-LIF and agarose gels, the cells were also plated into 100 mm culture dishes 
at a density of 5 million cells per dish and were cultured in medium with 4% serum for 24 
h before addition of the NO donor. The cells were incubated with the NO donor sodium 
nitropmsside (SNP) at 62.5, 125, 250, 500 and 1000 |LIM in the presence of 5% CO2 at 
37�C for 7 h. 
2.1.1.2 Culture of primary mouse uterine epithelial cells 
For the primary culture, the endometrial epithelial cells were enzymatically isolated 
from the C57BL/6J mouse uterus according to the method described by McCormack and 
Glasser for the isolation of rat uterine epithelial cells (McCormack and Glasser, 1980), 
except with the modifications introduced by Chan and coworkers for the isolation of ICR 
mouse uterine epithelial cells (Chan et al., 1997). For each culture preparation, samples of 
uterus were obtained from 40 C57BL/6J mice (4-6 week). The sliced uteri were incubated 
in PBS supplemented with 5 mg/ml trypsin and 25 mg/ml pancreatin at 0°C for 60 min and 
then room temperature for another 45 min. After the enzyme digestion, the conical 
centrifuge tube containing PBS and the tissue was shaken gently for 30 s. Uterine tissue 
was carefully removed, and the crude cell suspension was passed through a 70 |im 
fluorocarbon mesh filter (Spectra/Mesh, Spectrum, Houston, TX). The filtrate was 
centrifuged at 1000 X g for 5 min. The cell pellet was resuspended in 1 ml PBS and 
centrifuged again at 1000 X g for 5 min. The washing procedure was then repeated a 
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second time. After centrifugation, the cell pellet was resuspended in DMEM/Ham's F-12 
culture medium containing 10% fetal bovine serum, 1% non-essential amino acid (NEAA), 
100 U/ml penicillin, and 100 |Lig/ml streptomycin. The isolated endometrial cells were 
plated in 6-well culture plates and incubated at 5% CO2 at 37�C for 3 days. For the semm-
deprivation-induced apoptosis, cells were washed with PBS and incubated in 
DMEM/Ham's F-12 culture medium without serum for 3 days. For the NO-induced 
apoptosis, SNP (500 |iM, final concentration) was added to the medium (same as above) 
and incubated for 3 days. 
2.1.1.3 Culture of human ovarian epithelial cancer cells 
A 2 7 8 0 S cells (a cisplatin-sensitive human ovarian epithelial cancer cell line) were 
maintained at 37�C and 5% CO2 and 95% air in DMEM/F12 medium, supplemented with 
10% fetal bovine serum, 50 jug/ml streptomycin, 50 U/ml penicillin, 0.625 g/ml fungizone 
and 1% non-essential amino acids, as previously reported (Asselin et al 2001). Cells were 
plated at a density of 5 x lO"^  cells/cm^ in 6-well plates. After a 24 h cell-plating period, the 
culture medium was changed and the cells were treated with agonistic monoclonal anti-Fas 
antibody, ODQ or adenoviral XIAP sense cDNA under serum-free conditions. Serum 
withdrawal had no significant effect on cell viability during the experimental period, as 
confirmed by 3-(4,55-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide assay. 
2.1.2 Assessment of apoptotic DNA fragmentation 
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2.1.2.1 DNA extraction 
DNA was extracted by the following procedure. Epithelial cells in each plate/well 
were incubated with lysis buffer (5 mM Tris-HCl，0.5 % Triton X-100, and 20 mM EDTA, 
pH 8.0) by adding the lysis buffer directly to the plate/well. The pellets of the floating cells 
were collected after centrifugation and were added to the corresponding cell lysates. The 
cell lysates, together with the added floating cells, were mixed and incubated on ice for 15 
min. Then, cell lysates were centrifuged at 7000 g for 15 min at 4°C and the supematants 
were collected. DNA in supernatant fractions was extracted with phenol (supernatant: 
phenol, 1:1) and then extracted with phenol: chloroform: isoamyl alcohol (25:24:1). The 
fragmented DNA was precipitated in absolute ethanol (5:2) and sodium acetate (3 M, pH 
5.2) (10:1) at -20�C overnight. The DNA precipitate was collected by centrifugation of the 
sample at 14,000 rpm for 10 min at 4�C. The DNA pellet was washed in 70% ethanol and 
centrifuged at 13 000 rpm for 10 min at room temperature. The DNA pellet was then air 
dried, dissolved in TE buffer (5 mM Tris HQ, pH 8.0, 20 mM EDTA), treated with RNase 
(10 mg/ml) at room temperature for 1 h to remove RNA. 
2.1.2.2 Assessment of apoptotic DNA fragmentation by agarose gels 
Apoptotic DNA fragmentation in HRE-H9 cells was analyzed by DNA laddering 
on both 2% agarose gels and capillary electrophoresis with laser-induced fluorescence 
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detector (CE-LIF), a technique developed in our laboratory (Fiscus et al., 2001a; Fiscus et 
aL, 2001b; Fiscus 2002, Fiscus et al., 2002) (see below). Because of the limited number of 
primary uterine epithelial cells that could be collected from the mice, apoptotic DNA 
fragmentation in primary cultures was analyzed by CE-LIF only. Both floating cells and 
adherent cells were combined for the assessment of apoptosis. DNA in agarose gels was 
visualized using ethidium bromide (1 ^ig/ml) and a UV transilluminator (Sigma). 
2.1.2.3 Assessement of apoptotic DNA by CE-LIF 
The CE-LIF technique used dsDNAlOOO kit (Bio-Rad) to analyze the apoptotic 
DNA fragments, following a procedure previously developed in our laboratory for 
quantifying the levels of apoptosis in cultured HRE-H9 uterine epithelial cells (Fiscus et al., 
2001a) and neural (NlE-115, NG108-15 and PC 12) cells (Fiscus et al., 2001b; Fiscus, 
2002; Fiscus et al., 2002). Because the CE-LIF technique is >1,000 times more sensitive 
than agarose gels, it can measure apoptotic DNA fragmentation in just a few thousand cells, 
thus making the CE-LIF technique especially useful in experiments that involve primary 
cultures. Briefly, the procedure used a coated capillary (24 cm X 75 ^iM), electrophoretic 
injection at 10 kV for 2 s, run at 2.5 kV for 40 min at 4°C and an argon laser at 488 nm. 
The kits included SYBR Green I as the dsDNA-specific fluorescent label. Standards of 
known amounts of a 540 bp DNA fragment were run in the CE-LIF using identical 
conditions as the samples. The resulting standard curve was then used to calculate the 
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amount of apoptotic DNA in the 540 bp peaks, based on area under the peak/migration 
time. 
2.1.2.4 Assessement of apoptosis by Nuclear Hoechst 33248 Staining 
At the end of the culture period, cells attached to the growth surface were removed 
by trypsin treatment [trypsin (0.05%), EDTA (0.53mM); 3 7 � C , 1 min]. Attached and 
detached cells were pooled, pelleted, and resuspended in 10% neutral-buffered formalin 
containing Hoechst 33248 dye (12.5 ng/ml). Cells were spotted onto slides for microscopy. 
Nuclear staining was observed and photographed using a Zeiss fluorescence microscope 
(magnification 400X). Cells with typical apoptotic nuclear morphology (nuclear shrinkage, 
condensation, and fragmentation) were identified and counted, using randomly selected 
fields on numbered photographic slides to avoid bias. A minimum of 600 cells was 
counted in each treatment group. 
2.1.3 Assessement of protein content 
2.1.3.1 Protein extraction and Western blot analysis 
Cells were pelleted and lysed in ice-cold lysis buffer (pH 7.4) containing 50 mM 
Hepes, 150 mM NaCl, 1.5 mM MgCh, 1 mM EGTA, 100 mM NaF, 10 mM NaPPi, 10 % 
Glycerol and 1% Triton X-100. Protease inhibitors, PMSF (1 mM) and aprotonin (10 
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|Lig/ial), as well as 1 mM Na^VCU were added to the lysis buffer freshly. Cell lysates were 
then sonicated briefly (5 s/cycle, 3 cycles; 0 ^ C). The sonicates were incubated on ice for 1 
h and pelleted by centrifugation (15, 000 x g; 20 min). The supernatant was saved and 
stored at -20 °C for subsequent analyses. Protein concentration was determined using Bio-
Rad DC protein assay kit. Equal amounts of proteins (40 jag) were loaded and resolved by 
10% SDS-Polyacrylamide gel electrophoresis (PAGE) and electrotransferred (30V, 16 h) 
onto nitrocellulose membranes (Bio-Rad). Uniform protein loading was confirmed by 
comparing the intensity of stained total proteins between lanes of nitrocellulose 
membranes. The images were then scanned and stored electronically. The intensity of the 
protein stained in each lane was quantified for future reference or for normalization of 
Western blot results. Membranes were then blocked (room temperature, 1 h) with 5% 
Blotto (Tris-HCl (10 mM; pH 8.0), NaCl (150 mM), Tween 20 (0.05%, v/v; TBS-Tween 
20) containing skimmed milk (5%; w/v), then incubated overnight with primary antibodies 
[anti-PKG-Ia/p, (1:1000), anti-XIAP (1:2,000) or anti-GAPDH (1:4000)], and 
subsequently with horseradish peroxidase (HRP)-conjugated secondary antibody (1:2,500 
in 5% Blotto; room temperature, 1 h). Peroxidase activity was visualized with an ECL kit 
(Amersham Pharmacia Biotech, Arlington Heights, IL, USA) after three washes (each 15 
min) with TBS-Tween 20 and a single wash (10 min) with TBS [Tris-HCl (10 mM; pH 
8.0), NaCl (150 mM)]. Signal intersity was determined densitometrically and normalized 
against those of total proteins present in the corresponding lane on the membrane using 
Molecular Analyst software, version 1.5 Bio-Rad (Hercules, CA, USA). 
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2.1.4 Adenoviral infection of A2780s cells 
After 24 h of plating (10^ cells/60-mm culture dish), cells were infected with an 
adenoviral full-length XIAP sense cDNA or LacZ at a multiplicity of infection (MOI) of 0， 
2.5, 5 or 10 for 48 h, as previously described (Li et al 2001a). Adenovirus infection 
efficiency at MOI of 5, as determined by an X-gal staining assay against LacZ construct 
infected cells, was about 90%. The number of apoptotic cells was determined by Hoechst 
staining. XIAP protein contents were then assessed by Western blot. 
2.2 Preparation of solutions 
The working solutions and stock solutions were prepared as describled below. They 
are listed alphabetically. 
1 • 8-Br-cGMP was weighed and and dissolved in deionized water to the concentration 
required. 8-Br-cGMP was from Calbiochem. 
2. Adenoviral full-length Lac Z sense cDNA was diluted in culture medium to the MOI 
used. Lac Z sense DNA was prepared by the Adenovirus Core Facility, University of 
Ottawa Neuroscience Research Institute. 
3. Adenoviral full-length XIAP sense cDNA was diluted in culture medium to the MOI 
used. XIAP sense DNA was prepared by the Adenovirus Core Facility, University of 
Ottawa Neuroscience Research Institute. 
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4. Agarose gel (2%) was prepared by weighing 0.8 g of agarose to 40 ml of IX TAE. 1 
X TAE was prepared from 50 X TAE. Both agarose and 50 X TAE were from 
GIBCO BRL. 
5. Anti-GAPDH antibody was diluted 1:4000 in Blotto. Anti-GAPDH antibody (ab8245) 
was from Abeam. 
6. Anti-PKG-Ia/p antibody was diluted 1:1000 in Blotto. Anti-PKG-Ia/p antibody was 
from Calbiochem. 
7. Anti-XIAP antibody was diluted 1:2000 in Blotto. Rabbit polyclonal anti-human 
XIAP antibody was from Trevigen. 
8. Blotto (5%) contains Tris-HCl (10 mM; pH 8.0), NaCl (150 mM), Tween 20 (0.05%, 
v/v; TBS-Tween 20) and skim milk (5%; w/v). Tris-HCl was from Bio-Rad. NaCl 
was from Sigma, Tween-20 was from Fisher Scientific and skim milk was from 
Nestle. 
9. The DMEM used as the culture medium of the rabbit immortalized uterine epithelial 
cells, HRE-H9 cells contained phenol red, 4% heat-inactivated fetal bovine serum, 
100 U/ml penicillin and 100 |ag/ml streptomycin. DMEM, fetal bovine serum, 
penicillin and streptomycin were all from GIBCO BRL. 
10. The DMEM/Ham's F-12 used as the culture medium of the primary mouse uterine 
epithelial cells contained 10% fetal bovine serum, 1% non-essential amino acid 
(NEAA), 100 U/ml penicillin, and 100 |ag/ml streptomycin. DMEM/Ham's F12, fetal 
bovine serum, NEAA, penicillin and streptomycin were all from GIBCO BRL. 
19 
11. The DMEM/Ham's F-12 used as the culture medium of the human ovarian epithelial 
cancer cells, A2780s cells contained 10% fetal bovine serum, 1% non-essential amino 
acids (NEAA), 50 U/ml penicillin, 50 |ig/ml streptomycin and 0.625 g/ml fungizone. 
DMEM/Ham's F12, fetal bovine serum, NEAA, penicillin and streptomycin were all 
from GIBCO BRL. Fungizone was from Life Technologies, Inc./ BRL 
12. ECL™ (enhanced chemiluminescence) detected kits was from Amersham Amersham 
Pharmacia Biotech. 
13. Ethanol (70 %) was prepared by diluting absolute ethanal in deionized water. 70% 
ethanol was used for washing DNA pellet, while absolute ethanol is used with sodium 
acetate for precipitating DNA. Absolute ethanol was from Merck. 
14. Ethidium bromide was weighed and dissolved in deionized water to prepare the stock 
of 10 mg/ml. 2 \i\ of stock of ethidium bromide (1 |ig/ml) was added to 40 ml of 2% 
agarose gel for visualization of DNA by using a UV transilluminator. Both ethidium 
bromide and UV transilluminator were from Sigma. 
15. Hank's Balanced Salt Solution (HBSS, without phenol red) was used for washing 
HRE-H9 cells before passaging or harvesting by trypsinization. HBSS was from 
Sigma 
16. Hoechst 33248 dye was weighed and dissolved in deionized water to prepare the 
stock of 6.25 \xg/[i\. 2 \x\ of Hoechst staining stock solution was diluted in 1 ml of 
buffered formalin to obtain a final concentration of 12.5 ng/ml. 40 |LI1 of final Hoechst 
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staining solution in buffered formalin was used for resuspending cell pellets. Hoeschst 
staining dye was from Sigma 
17. Horseradish peroxidase (HRP)-conjugated secondary antibody diluted 1:2000 in 
blotto for anti- PKG-Ia/p and diluted 1:2500 in Blotto for anti-XIAP and anti-
GAPDH. Horseradish peroxidase (HRP)-conjugated secondary antibody was from 
Amersham Amersham Pharmacia Biotech. 
18. KT5823 was weighed and diluted in deionized water to the concentration required. 
KT5823 was from Calbiochem. 
19. Lysis buffer (for DNA extraction) contains 5 mM Tris-HCl, 0.5 % Triton X-100 and 
20 mM EDTA. The lysis buffer was adjusted to pH 8.0. Tris-HCl and Triton X-100 
were from Sigma and EDTA was from GIBCO BRL. 
20. Lysis Buffer (for protein extraction) contains 50 mM Hepes, 150 mM NaCl, 1.5 mM 
MgCh, 1 mM EGTA，100 mM NaF, 10 mM NaPPi, 10 % Glycerol and 1% Triton X-
100. Protease inhibitors, PMSF (1 mM) and aprotonin (10 |ig/|il), as well as 1 mM 
Na3V04 were added to the lysis buffer freshly. The lysis buffer was adjusted to pH 
7.4. All chemicals were from Sigma. 
21. Monoclonal agonistic anti-Fas antibody (Fas mAb) was diluted in culture medium to 
the concentration required. Fas mAb was from Upstate Biotechnology. 
22. Mouse IgM was diluted in culture medium to the concentration required. Mouse IgM 
was from Upstate Biotechnology 
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23. Neutral-buffered formalin (10%) was used for resuspending and fixing cells for 
nuclear Hoechst staining. Neutral-buffered formalin was from Sigma. 
24. ODQ was weighed and diluted in DMSO first and then diluted to the concentration 
required in culture medium. ODQ was from Calbiochem. DMSO was from Sigma. 
25. Phenol was used for the first step of DNA extraction. DNA was extracted first by 
adding phenol in a one-to-one ratio to the supernatant of the sample. Phenol was from 
GIBCO BRL. 
26. Phenol: chloroform: isoamyl alcohol (25:24:1) mixture was used for the final 
extraction of the DNA. The mixture was added in one-to-one ratio to the supernatant 
of the sample. Chloroform and isoamyl alcohol were from Sigma while phenol was 
from GIBCO BRL. 
27. Phosphate Buffer Saline (PBS) supplemented with 5 mg/ml trypsin and 25 mg/ml 
pancreatin was used for preparing mouse uterine epithelial cells from mouse uterus by 
enzymatic digestion. PBS and pancreatin were from GIBCO BRL. Typsin was from 
Sigma. PBS by itself was used for washing primary mouse uterine epithelial cells 
before passaging or harvesting by trysinization. 
28. RNase was weighed and dissolved in deionized water to prepare a stock of 10 mg/ml. 
1 |LI1 of stock was added to the 20 \x\ DNA sample in TE buffer for digesting unwanted 
RNA. RNase was from Roche. 
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29. Running Buffer, 5 X stock solution was prepared by adding 15.14 g of Tris, 93.94 g 
of glycine, 5 g of SDS to 1000 ml of deionized water. Tris, glycine and SDS were all 
from Bio-Rad. 
30. Sodium acetate was weighed and dissolved in deionized water to prepare the stock at 
a concentration of 3 M. Stock of sodium acetate was adjusted to pH 5.2. Sodium 
acetate was used with absolute ethanol for precipitating DNA. Sodium acetate was 
from Sigma. 
31. Sodium Dodccyl Sulphate (SDS) (10 %) was prepared by dissolving 10 g of SDS into 
100 ml of deionized water. The mixture was placed in 37-55 hot water bath until 
the solution was clear. SDS was from Bio-Rad. 
32. Sodium nitropmsside (SNP) was prepared freshly in every experiment. SNP was 
weighed and dissolved in deionized water to obtain the concentration required. SNP 
was from Sigma. 
33. SYBR Green I was used as the dsDNA-specific fluorescent label. 2 jil of SYBR 
Green I was added to 2 ml run buffer. Both SYBR Green I and the run buffer were 
from the dsDNA 1000 kit, which was from Bio-Rad. 
34. TE buffer contained 5 mM Tris HCl and 20 mM EDTA in deionized water. TE buffer 
was then adjusted to pH 8.0. TE buffer was used for dissolving DNA for both agarose 
gel electrophoresis and CE-LIF. Both Tris HCl and EDTA were from GIBCO BRL. 
35. Transfer Buffer, 5 X stock solution was prepared by adding 15.14 g Tris and 72.16 g 
of Glycine to 1000 ml of deionized water. The working solution of transfer buffered 
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was prepared by adding 200 ml of 5 X stock solution of transfer buffer and 200 ml of 
methanol to 600 ml of deionized water. Both Tris and glycine were from Bio-Rad. 
Methanol was from Sigma. 
36. Tris 1.0 M was prepared by adding 12.11 g of Tris to 100 ml of deionized water. The 
pH of Tris was adjusted to 7.4. Tris was from Bio-Rad. 
37. Tris-Buffered Saline (TBS), 10 X stock solution was prepared. 12.11 g of Tris and 
87.65 g of NaCl was weighed and added to 1000 ml of deionized water. The mixture 
was stirred and adjusted to pH 7.2. TBS working solution was prepared by one-to-10 
dilution. Tris was from Bio-Rad and NaCl was from Sigma. 
38. Tris-Buffered Saline with Tween (TBS-T) was prepared by adding 400 ml of 10 X 
TBS stock solution to 3600 ml deionized water. Two ml of Tween-20 was added to 
the mixture. Tween-20 was from Fisher Scientific. 
39. Typsin (0.05%) for harvesting cells by trypsinization was purchased from Sigma. 
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2.3 Animals and cell lines 
The HRE-H9 rabbit uterine epithelial cell line was obtained from Dr. Lih-Yuh C. 
Wing (National Cheng Kung University Medical College, Tainan, Taiwan). The HRE-H9 
cells were originally developed by immortalizing primary cultures of endometrial 
epithelial cells, derived from hCG-treated pseudopregnant rabbits, with SV40 temperature-
sensitive (ts) mutant virus (Li et al., 1989; Chen et al., 1991). Cisplatin-sensitive (A2780-s) 
human ovarian epithelial cancer cell lines were gifts from Drs. R. Goal and B. 
Vanderhyden (Ottawa Regional Cancer Center, Ottawa, Ontario, Canada). Male C57BL/6J 
mice (30-35g) (4-6 weeks) were an inbred strain imported from Animal Resource Centre 
of Australia, originating from Jackson Laboratory of the USA. 
2.4 Statistical analysis 
The data of the amounts of DNA fragmentation were presented as mean 士 SEM. 
The n value indicates the number of individual experiments conducted. The comparisons 
between groups of data were made by Student paired t-tests, if there were only two 
treatment groups. If the number of treatment groups were more than two, the comparisons 
between groups of data were made by one-way analysis of variance, followed by Tukey's 
test. All analyses were performed using the software GraphPad Prism (Version 3.0, 
GraphPad Software, Inc., San Diego, California, USA; www.graphpad.com). 
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Chapter 3: Literature Review 
3.1 Morphological Analysis of Physiological Cell Death 
Organisms use physiological cell death for a variety of reasons. The term 
"apoptosis" is often used to describe the physiological death of mammalian cells (Kerr et 
al., 1972; Wyllie et al., 1980). When individual cells die in a healthy organ, their death is 
not accompanied by changes that are characteristic of pathological cell deaths. The term 
"programmed cell death" is commonly used synonymously with apoptosis. Apoptosis is 
more of a descriptive term, whereas programmed cell death implies that the decision to die 
was made cell-autonomously, independently of any other cells. Apoptosis is associated 
with death of isolated cells, rather than contiguous patches or areas of tissue; there is no 
inflammatory infiltrate; nuclear shrinkage and intemucleosomal fragmentation of the DNA 
occurs relatively early, but changes to the organelles and loss of membrane integrity are 
relatively late; the dying cells are phagocytosed by neighboring cells. 
Necrosis，a pathological cell death, affects many adjoining cells (Searle, et al., 
1982). It is characterized by cell swelling, with early loss of plasma-membrane integrity 
and major changes to the organelles, and the nucleus tends to swell. Necrosis is 
accompanied by an inflammatory infiltrate of phagocytic cells. 
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3.1.1 Characteristics of Apoptosis 
In apoptosis, phagocytic cells normally sequester antigenically modified apoptotic 
cells, preventing inflammation and damage to the surrounding tissue (Duvall et al., 1985). 
Morphological and biological changes during apoptosis include loss of intracellular water 
and this leads to condensation of the cytoplasm followed by cellular shrinkage and 
membrane blebbing. There is also chromatin condensation or aggregation and extensive 
genomic fragmentation in apoptotic cells (Kerr et al., 1972). The condensation starts at the 
nuclear periphery, and the condensed chromatin often takes on a concave shape resembling 
a half-moon, horseshoe, or sickle. DNA in condensed chromatin exhibits hyperchromasia, 
staining strongly with fluorescent or light absorbing dyes. Besides, there is DNA 
fragmentation into nucleosomal units of about 200 bp fragments. DNA cleavage occurs at 
intemucleosomal Under region, resulting in ladder formation of DNA of 180-200bp or 
multiples thereof on agarose gel electrophoresis (Compton, 1992). The reason for the 
2+ 2+ 
ladder type of fragmentation has been attributed to the activities of Ca /Mg -activated 
endonucleases. 
Furthermore, apoptotic cells may cause formation of apoptotic bodies. The nuclear 
fragments, together with constituents of the cytoplasm (including organelles), are packaged 
and enveloped by fragments of the plasma membrane. These structures, called 'apoptotic 
bodies' are then shed from the dying cell. However, in necrosis, the nucleus undergoes 
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slow dissolution and there is release of intracellular constituents, including proteolytic 
enzymes, into the surrounding space. This evokes an inflammatory reaction with local 
cellular infiltration, vascular damage, edema, and injury to the surrounding tissue. Table 
3.1 summarizes the comparative features of necrosis and apoptosis and diagram 3.1 shows 
the schematic diagram of the morphological changes in necrosis and apoptosis. 
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Table 3.1: Comparative features of necrosis and apoptosis 
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Necrosis Apoptosis 
Passive atrophy Active, highly regulated degeneration 
Cell response to gross injury or cytotoxic Intrinsic cellular suicide program 
agents 
Loss of cellular homeostasis No initial major changes 
Altered membrane permeability, membrane Not seen, at least initially. Preservation of 
lysis and rupture structural integrity and most of plasma 
membrane functions 
Potassium loss; sodium entry; fall in No sodium influx; no change in potassium 
membrane potential concentration in cell 
Swelling of all cytoplasmic compartments Cell dehydration, cellular shrinkage, 
membrane blebbing, Cytosol and nuclei 
condensation 
Destruction of mitochondria and other Generally intact organelles, preservation of 
organelles. Release of intracellular constituents cellular organelles, including mitochondria 
which include proteolytic enzymes and lysosomes 
Protmberances from cell surface separate to 
form apoptotic bodies 
Depletion of cellular energy (ATP) No depletion of cellular energy 
Lowered macromolecular synthesis Macromolecular synthesis activation is 
required 
Affects tracts of contiguous cells Affects scattered individual cells 
Loose aggregates of chromatin Highly condensed granular aggregates of 
chromatin 
DNA degradation is not so extensive, product DNA fragmentation, DNA cleaved at 
of degradation are heterogenous size intemucleosomal Under region 
Summarized from Kerr et al., 1972, McConey et al., 1988, Compton, 1992, Kypianou, et 
al., 1988, Schwartz et al., 1993 
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Diagram 3.1: Schematic diagram of the morphological changes in necrosis and 
apoptosis 
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Diagram source from Cell Signaling Technology 
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3.2 Methods of detecting apoptosis 
Many parameters have been used to examine cell death. Numerous methods have 
been developed to identify apoptotic and necrotic cells and are widely used in various 
disciplines, in particular in oncology and immunology. The methods are based on changes 
in cell morphology, plasma membranes structure and transport function, function of 
organelles, DNA stability to denaturation, and endonucleolytic DNA degradation. 
There are a few methods detecting apoptotic cells based on the characteristic of 
DNA fragmenatation. During DNA fragmentation, DNA is first cleaved into 300kb and 
50kb fragments initially (Brown, et al., 1993), then to characteristic 180-200bp 
intemucleosomal fragments. Multiples of the 180-200bp fragments result in a 
characteristic DNA ladder pattern upon electrophoresis (Wyllie, 1987). Although apoptotic 
DNA fragmentation is a comon feature of apoptosis in most cells, cell death can still occur 
in cells lacking the endonucleases needed for apoptotic DNA fragmentation (Nagata. 2000). 
In these cells, the activation of other pathways can lead to cell death. Nevertheless, 
apoptotic DNA fragmentation is considered a hallmark of apoptosis in the vast majority of 
cells. Various techniques, including gel electrophoresis, TUNEL (terminal 
deoxynucleotidyl transferase-mediated dUTP nick end-labeling) (Kerr et al., 1994; Nagata, 
2000) and capillary electrophoresis (Evans et al., 1995; Solis-Recendez et al., 1995; Siles 
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et al , 1997; Fiscus, 2002; Fiscus et al., 2002) have been used to identify DNA 
fragmentation in apoptotic cells. 
DNA condensation feature can also be used to recognize apoptosis. During 
apoptosis, nuclear DNA condenses and marginates to the inside of the nuclear membrane 
(Wyllie et al., 1980). The mechanism for these changes is not known but may be due to 
cleavage of nuclear lamina and nuclear scaffold attachment factor (Lincz 1998). Flow 
cytometry and nuclear Hoechst staining utilizing individual cell features of apoptosis to 
serve as markers for detection and analysis of the proportion of apoptotic cells in the cell 
population studied. 
Another method identifying apoptosis is detection of phosphatidylserine with 
annexin V. Pho sphatidyl s erine is located on the inner leaflet of the plasma membrane in 
non-apoptotic cells, and it is translocated to the extracellular side when apoptosis sets in 
(Adayev et al., 1998). The extemalisation to the outer leaflet is an early event in apoptosis. 
Phosphatidylserine extemalisation may be a signal to phagocytes, although this has been 
shown not to be an absolute requirement for macrophage recognition. Phosphatidylserine 
acts as a procoagulant, an effect that is reversed when bound to annexin V (Lincz. 1998). 
Therefore, annexin V labelling can be used to identify apoptotic cells. 
Appropriate antibodies to one or more of the cleaved fragments of poly (ADP-
ribose) polymerase, which is cleaved by an interleukin-1 p-converting enzyme (ICE)-like 
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protease in apoptotic cells, can also be used (Duriez and Shah, 1997). In situ 
immunodetection of activated caspase-3, which recognize the p i8 subunit of caspase 
formed during apoptosis can also be used (Srinivasan et al., 1998). 
3.3 Molecules controlling apoptosis 
The process of apoptosis is mainly controlled by two main groups of molecules, 
caspases and Bcl-2 family proteins. 
3.3.1 Caspases 
A novel family of cysteine proteases in the execution of programmed cell death in 
organisms as diverse as from worms to human has been identified. The name "caspases" 
was given to the family of cysteine proteases with aspartic acid substrate specificity. The 
morphological and cellular changes of apoptosis are due, directly or indirectly, to the 
actions of caspases. Caspases are expressed as zymogens; the active enzymes are thought 
to be tetramers derived from two pro-caspase molecules, containing the large and small 
subunits (Cohen, 1997). 
At least 14 caspases have been identified in mammals with a uniform nomenclature 
from caspase-1 to caspase-14 (Alnemri et al., 1996; Nicholson and Thomberry, 1997). 
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According to their functions in the apoptotic signaling pathway, these caspases are divided 
into two catagories: the so-called initiator caspases (e.g. caspase-8 and caspase-9) that 
trigger the activation of the so-called effector or execution caspases (e.g. caspase-3, 
caspase-6 and caspase-7), that function to interact with other caspases and non-caspase 
molecules to induce apoptosis by cleaving the cellular substrates. It is well accepted that 
caspases are not only responsible for degradation of cellular substrates during the end stage 
of apoptosis, but also are the critical regulators of cell death initiation. 
Since caspase activation is the committed step to apoptosis and given the cascade 
nature of caspase activation, the correct control of caspase activation and thus apoptosis is 
vital. Thus far, three general mechanisms of caspase activation have been introduced. The 
simplest way of activating a procaspase is to expose it to another previously activated 
caspase molecule. The second way of activating procaspase is binding of some ligands. 
Upon ligand binding, death receptors, such as CD95 (Apo-l/Fas), aggregate and form 
membrane-bound signaling complexes. These complexes then recruit, through adaptor 
proteins, several molecules of procaspase-8. This results in localization of high 
concentration of zymogen. Under these crowded conditions, the low intrinsic protease 
activity of procaspase-8 is sufficient to allow the various proenzyme molecules to mutually 
cleave and activate each other. The third way of inducing apoptosis is through association 
with regulatory cofactors. For example, association with a dedicated protein cofactor, 
Apaf-1 causes activation of caspase-9. 
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3.3.2 Bd-2 family proteins 
Besides caspases, the Bcl-2 family of proteins is also involved in the control of 
apoptosis. Bcl-2 is named after the founding member of the family, which was isolated as a 
gene product involved in B-cell lymphoma (Tsujimoto et al., 1985). The Bcl-2 family 
proteins share one or more of 4 Bcl-2 Homology domains, BHl, BH2, BH3 or BH4. Up to 
now, 15 Bcl-2 family proteins have been identified in mammals; some are pro-apoptotic, 
whilst some are anti-apoptotic. The Bcl-2 family proteins can be classified into three 
groups (Adams and Cory, 1998; Antonsson and Martinou, 2000). Group I members 
contain all four domains and they all possess a C-terminal hydrophobic tail, which 
localizes the proteins to the outer surface of mitochondria and occasionally of endoplasmic 
reticulum (ER) with the bulk of the protein facing the cytosol. All group I members are 
anti-apoptotic. Group II members are pro-apoptotic. Members of this group lack the most 
N-terminal BH4 domain. Group III members consists of a large and diverse collection of 
proteins whose only common feature is the presence of the 12-16 amino acid BH3 domain 
(Kelekar and Thompson, 1998). 
The principle mechanism by which Bcl-2 family proteins regulate apoptosis is to 
control the translocation of cytochrome c from mitochondria to cytosol (Jacobson, 1997; 
Kelekar and Thompson, 1998; Newton and Strasser, 1998; Reed, 1998). Translocation of 
the pro-apoptotic Bcl-2 proteins to mitochondria plays the major role in causing 
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cytochrome c release (Gross et al., 1999; Jacobson, 1997; Kroemer and Reed, 2000; 
Newton and Strasser, 1998). It is thought that the relative concentrations of pro- and anti-
apoptotic Bcl-2 family members provide the control over a cell surviving or undergoing 
apoptosis. The main protagonists are suggested to be Bax and Bcl-2. Apoptosis can be 
prevented if the concentration of Bcl-2 is enough to complex with at least half of the Bax. 
Control of the expression of Bcl-2 family members is actually regulated by other proteins 
important in the apoptotic process. 
3.4 Apoptosis signaling 
The recently booming field of cell death research has focused on particular 
signaling pathways. At least three distinct caspase-signaling pathways exist; one activated 
through ligand-dependent death receptor oligomerization, the second through 
mitochondrial disruption, and the third through stress-mediated events involving the 
endoplasmic reticulum. These pathways also appear to interact to amplify weak apoptotic 
signals and shorten cellular execution time. 
3.4.1 The death receptor-dependent pathway 
The death receptor-dependent pathway is mainly present in cytokines-induced 
apoptosis (Gabuzda and Wang, 2000; Sidoti-de Fraisse et al., 1998). The tumor necrosis 
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factor receptor (TNFR) family of proteins plays an important role in the mediation of 
apoptosis or programmed cell death in diverse biological systems (Smith et al., 1994; 
Gmss and Dower, 1995; Baker and Reddy, 1996). Three members of this family are 
TNFRl, Fas/Apo-1 (CD95), and death receptor 3 (DIG) (Wsl-1, Apo-3, and TRAMP). 
Some of these receptors are homologous to each other in extracellular cysteine-rich 
domains, but also in a cytoplasmic 'death domain，(Itoh and Nagata, 1993; Tartaglia et al., 
1993). The death domain is required for protein-protein interaction that ensures down-
stream cell death signaling and thus causes induction of apoptosis (Cleveland and Ihle, 
1995, Chinnaiyan et al., 1996; Kitson et al., 1996; Marsters et al., 1996; Bodmer et a l , 
1997). The rapid induction of cell death via the death domain is unique to the TNFR 
superfamily. 
Engagement of the receptors by Fas ligand (Fas-L) or by TNF (or lymphotoxin), 
respectively, can lead to cell death (Nagata and Golstein, 1995; Baker and Reddy, 1996; 
Yuan, 1997; Wong and Choi, 1997). These ligands and receptors were the first known 
members of a multilevel molecular system connecting extracellular signals and the 
intracellular cell-death cascade. TNFRl or Fas were suspected to utilize cellular proteins as 
"downstream messengers of death". To date, several death domain-containing proteins, 
which associate with either INFRl or Fas, have been identified and characterized with 
respect to their ability to induce apoptosis and other downstream signaling events, which 
are activated in immune responses achieved through ligand binding to this receptor. 
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On activation by the receptor's ligand, the death domain recruits various proteins 
that mediate cell death. These proteins, in turn, recruit other proteins via their death 
domains or death effector domains (DED). The actual destruction of the cell, however, is 
accomplished by serial activation of a family of proteases referred to as caspases. For 
example, binding of TNF or FasL to their receptors leads to recruitment of a variety of 
death domain-bearing adaptor proteins such as Fas associated death domain (FADD). 
FADD then recruits the most upstream procapases (pro-caspase-8 and -10) to the receptor 
complex via a distinct protein interaction module DED, resulting in auto-proteolysis of 
these initiator caspases. The activation of caspase-8/-10 may either initiate a proteolytic 
cascade of the downstream executioner caspases such as caspase-3 causing demise of the 
cell (Cryns and Yuan, 1998) or cleave certain pro-apoptotic Bcl-2 family proteins such as 
Bid, facilitating it translocation to mitochondria to induce cytochrome c release 
(Budihardjo et al., 1999). 
3.4.2 The mitochondria-dependent pathway 
Mitochondria are involved in cell death for reasons that go beyond ATP supply. 
Mitochondria can be considered as the heart of the apoptotic machinery. It is the 
converging site of many apoptotic signaling pathways which are stimulated by different 
apoptotic inducers. Mitochondria contain and release proteins that are involved in the 
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apoptotic cascade, like the caspase activator cytochrome c and apoptosis inducing factor 
(AIF) (Cai et al., 1998; Reed, 1997; Susin et al., 1998). Physiologically, cytochrome c is 
one of the electron carriers in the respiratory chain, which is localized in the 
intermembrane space of the mitochondria. Mitochondrial cytochrome c has been found to 
have dual functions in controlling both cellular energetic metabolism and apoptosis. In 
mammalian cells, once cytochrome c is in the cytosol, it will bind to apoptotic protease 
activating factor (Apaf-1). In the presence of ATP or dATP, the complex of cytochrome c 
and Apaf-1 recruits and activates pro-caspase-9. The activated caspase-9 then activates 
other caspases, such as caspase-3, which are responsible for cleaving intracellular proteins, 
leading to apoptotic DNA fragmentation and eventually cell death (Desagher and Martinou, 
2000). 
3.4.3 The Endoplasmic Reticulum-dependent pathway 
The endoplasmic reticulum (ER) serves several important functions, including 
post-translational modification, folding and assembly of newly synthesized secretory 
proteins, and a cellular calcium store. Proper function of the ER is essential to cell survival 
and any perturbation of its function may induce cellular damage and results in apoptosis. 
Recent studies indicated that the ER is the organelle that can sense cellular stresses leading 
to apoptosis and transduce apoptotic signals. These cellular stresses include disruption of 
ER calcium homeostasis and the accumulation of excess protein in the ER. Uniquely, 
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caspase-12 acts as an initiator of stress-induced apoptosis through the ER despite its 
dissimilarity to the ‘initiator，caspase-8 and -9 (Nakagawa et al., 2000). 
Pro-caspase-12, predominately situated on the cytosolic side of ER membrane, can 
be activated by an imbalance in ER homeostasis (Nakagawa and Yuan, 2000; Nakagawa et 
al., 2000). The activated caspase-12 then activates the downstream effector caspases either 
directly or indirectly (Nakagawa and Yuan, 2000). 
3.5 Importance of apoptosis in female reproductive system 
3.5.1 Apoptosis in uterine epithelial cells 
Both apoptosis and proliferation play essential roles in the homeostasis of 
renewable tissues. Apoptosis is now recognized as an important event in the development 
and function of the reproductive system (Gosden and Spear, 1997). Progressive increases 
in apoptosis occur in uterine epithelial cells during the secretory and menstrual phases of 
the menstrual cycle in humans (Tabibzadeh, 1995) and the estrous cycle in rats (Sato, et al, 
1997). Thus, the apoptosis of uterine epithelial cells is thought to play an important role in 
the regulation of the menstruation cycle and abnormalities in the regulation of epithelial 
apoptosis may thus result in dysmenorrhea. 
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Implantation of an embryo into the wall of the uterus also involves apoptosis of 
epithelial cells. Uterine epithelial cells surrounding the embryos during implantation 
undergo apoptosis and this leads to the phagocytosis of the epithelial cells by trophoblast 
cells in mice and rats (Parr et al., 1987; Kamijo et al., 1998). Therefore, induction of 
apoptosis of endometrial epithelial cells may represent an essential cellular event for 
successful implantation. A lack of proper apoptosis of uterine epithelial cells during 
implantation is thought to be one of the causes of infertility. Mechanisms of apoptosis in 
endometrial epithelial cells during trophoblast invasion, however, remain to be established 
(Pampfer and Donnay, 1999). 
Another condition associated with abnormal apoptotic responses in uterine 
epithelial cells is endometriosis. Gebel et al., (1998) showed that spontaneous apoptosis of 
endometrial tissue is impaired in women with endometriosis. Thus, abnormal growth and 
impaired sensitivity to spontaneous apoptosis in uterine epithelial cells is thought to cause 
endometriosis. 
Bcl-2 is expressed in all the components of the endometrium but at different phases 
of the menstrual cycle. Bcl-2 expression is concordant geographically and chronologically 
with proliferation. It starts in the glandular epithelium at the bottom of functional layer and 
gradually spreads to all the glands. This expression is most intense in the basalis glands, 
gradually diminishing in the mid and upper functionalis glands (Tabibzadeh et al., 1995; 
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Gompel et al., 1994; Otsuki et al., 1994). Bcl-2 expression peaks at the proliferative phase. 
Three days after ovulation, most epithelial cells with the exception of some residing in the 
basalis, become bcl-2 negative for the duration of the secretory phase. Bcl-2-negative 
endometrial cells can become susceptible to signals inducing apoptosis. Apoptosis appears 
in endometrium simultaneously with the disappearance of bcl-2. Persistent expression of 
bcl-2 in the epithelial cells residing within the basalis may account for the specific 
privilege that these cells have to escape apoptosis, allowing these cells to contribute to the 
repair of the endometrium after menstruation. 
3.5.2 Apoptosis in ovarian cancer cells 
Ovarian cancer is the most lethal gynaecological cancer in the Western world and 
ranks fifth among the most common female cancers (Wingo et al., 1995). More than 20, 
000 women in North America are diagnosed with ovarian cancer each year and more than 
12,000 die from the disease. Among all kinds of human ovarian malignancies, epithelial 
ovarian tumors, which originate from the simple epithelium covering the surface of the 
ovary, account for over 85%. 
Little is known about the biomolecular processes governing the initiation and 
spread of ovarian cancer. However, it is well accepted that alterations in normal cell 
proliferation, including increased cell growth and/or decreased cell death, cause an 
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imbalance in tissue homeostasis. This may contribute to the initiation and progression of 
tumor growth (Thompson, 1995). Thus, apoptosis plays an important role in maintaining 
normal ovarian functions and a delicate balance between cell growth and cell death helps 
to ensure normal ovarian functions. 
Recent research has revealed the presence of several potent endogenous suppressers 
of apoptosis, the inhibitor of apoptosis proteins (lAPs), in mammalian cells. lAPs were 
first identified in baculoviruses, where they keep the host cells alive while the viruses 
replicate (Bimbaum et al., 1994; Crook et al., 1993). The lAP family currently consist of 
six members: neuronal apoptosis inhibitory protein (NAIP) [Roy et al., 1995], X-linked 
inhibitor of apoptosis protein (XIAP) (Liston et al., 1996; Uren et al., 1996; Duckett et al., 
1996), human inhibitor of apoptosis protein-1 (HIAP-1) (Liston et al., 1996; Uren et al., 
1996; Duckett et al., 1996), human inhibitor of apoptosis protein-2 (HIAP-2) (Liston et al., 
1996; Uren et al., 1996; Rothe et al , 1995), survivin (Ambrosini et al., 1997) and Livin 
(Kasof and Gomes, 2001). With the exception of NIAP and survivin, which only have the 
N-terminal repeats named baculovirus LAP repeats (BIRs; required for biologic function), 
all the other mammalian lAPs identified to date possess both N-terminal BIRs and a C-
terminal RING-zinc finger domain, which is required for protein-protein interaction. 
The role of XIAP in the regulation of apoptosis in human ovarian cancer has been 
examined recently. XIAP is localized in human ovarian carcinomas, in which there are 
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higher levels of XIAP in proliferative epithelial cancer cells compared to apoptotic 
epithelial cancer cells (Li et al., 2000; Li et al., 2001a). The pro-apoptotic agent cisplatin, a 
chemotherapeutic agent commonly used in the treatment of ovarian cancer, has been 
shown to decrease the expression of XIAP, and this response is thought to contribute to the 
development of apoptosis caused by cisplatin (Li et al., 2000; Li et al., 2001a). XIAP has 
been shown to suppress apoptosis via caspase -3 and -7 inhibition (Deverasaux et al., 1997; 
Takahashi et al., 1998) as well as interfering with the Bax/cytochrome c pathway by 
inhibiting caspase-9 (Deveraus et al., 1998, 1999). Over-expression of lAPs has been 
shown to have an anti-apoptotic effect in mammalian cells. For example, over-expression 
of NIAP, XIAP, HIAP-1 or HIAP-2 protects Chinese hamster ovary (CHO) and RAT-1 
cells from apoptosis triggered by menadione (Liston et al., 1996) and over-expression of 
XIAP or HIAP-2 protects HeLa cells from apoptosis induced by transient transfection of 
pro-interleukin-1 p-converting enzyme (Uren et al., 1996). Furthermore, over-expression of 
XIAP in human ovarian epithelial cancer cells markedly attenuates cisplatin-induced 
apopotosis (Asselin et al., 2001; Li et al., 2001a). Therefore, the lAPs appear to play key 
roles in the regulation of apoptosis in cancer cells. 
3.6 Regulation of Apoptosis by Nitric Oxide/cGMP/Protein Kinase G 
3.6.1 Regulation of apoptosis by Nitric Oxide 
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Nitric oxide (NO) is a free-radical molecule generated from L-arginine through the 
action of NO synthase (NOS). In addition to its role as an endothelium-derived relaxing 
factor (Moncada et al., 1991), NO also regulates platelet adhesion and aggregation 
(Radomski et al., 1987; Radomski et a l , 1990)，leukocyte recruitment and activation 
(Kubes et a l , 1991), and cytokine-induced endothelial cell activation (De catarina et al., 
1995). NO is potentially cytotoxic under pathological conditions such as septic shock, 
inflammation (Brown, 1997), myocardial infarction, and atherosclerosis (Radomski and 
Salas, 1995). 
Despite clear evidence that NO plays an important role in the physiological and 
pathological processes, there is increasing evidence that NO mediates cell death either via 
necrosis or via apoptosis. However, effect of NO on apoptosis is contradictory. In some 
situations, NO activates the transduction pathways leading to apoptosis. However, in other 
cases, NO protects cells against spontaneous or induced apoptosis. Actually, NO's effect on 
apoptosis depends on many factors, such as NO concentration, flux and cell types. 
NO is known to induce apoptosis in a number of different kinds of cells including 
activated macrophages of mice (Albina et al., 1993; Sarih et aL, 1993), rat vascular smooth 
muscle cells (Fukuo et al., 1996), and rat neurons (Bonfoco et al., 1995). Moreover, there 
is evidence that cytokines and a variety of chemical NO donors induce apoptosis in freshly 
isolated rat islets and clonal pancreatic B-cell lines (Loweth, 1997; Kaneto et a., 1995; 
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Rabinovitch et al., 1994; Ankarcrona et al., 1994), as well as pulmonary epithelial cells 
(Janssen et al., 1997). Up to now, the mechanisms by which NO induces apoptosis still 
remains undefined. It has been proposed that NO toxicity involves its reaction with 
superoxide to form the strong oxidant peroxynitrite (Beckman, 1991; Beckman et al., 1993: 
Dawson et al., 1993; Lipton et al., 1993; Troy et a l , 1996; Estevez et a l , 1998). NO is also 
known to cause direct damage to DNA by deamination of purines and pyrimidines 
(Nguyen et a l , 1992), in addition to exerting inhibitory effects on metabolic enzymes. 
Besides, NO also inhibits mitochondrial respiration and induces Ca^^ efflux (Balakirev et 
al., 1997). In addition, NO can also modulate the mitochondrial permeability transition (PT) 
(Hortelano et al., 1997)，a process that is linked to release of apoptogenic factor such as 
cytochrome c. Furthermore, it has recently been reported that the apoptotic actions of NO 
in insulin producting HIT-T15 cells are mediated by the sGC/PKG system (Loweth et al., 
1997). 
Although in many experimental systems NO may favour cell death and even 
apoptosis, in others NO production may exert a protective effect, either through sGC-
dependent or -independent mechanisms (Kolb et al., 2000; Kim et al., 1997). NO has 
recently emerged as a novel and potent inhibitor of apoptosis. Endogenous NO synthesis or 
exposure to low level NO donors was first shown to inhibit apoptosis in human B 
lymphocytes (Mannick et al., 1994), and similar findings have been reported in splenocytes 
(Genaro et al., 1995), eosinophils (Beauvais et al., 1995), cardiac myocytes (Cheung et al., 
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1995), and endothelial cells (Dimmeler et al., 1997). 
It has been reported that NO prevents hepatocyte apoptosis initiated by the removal 
of growth factors or exposure to TNF-a or anti-Fas antibody (Kim et a.，1997). The nitric 
oxide donors, azide and hydroxylamine were able to inhibit in vitro the programmed cell 
death of human eosinophils from peripheral blood (Beauvais et al., 1995). Treatment with 
IL-ip, which stimulated NO production, dose-dependently suppressed the spontaneous 
onset of apoptosis in ovarian follicles (Chun et al., 1995). NMD A, which can stimulate 
production of nitric oxide and in turn enhance synthesis of cGMP, enhances the survival of 
cerebellar granule cells and protects the cells against ethanol-induced cell death by a 
mechanism that involves the NO/cGMP pathway (Pantazis et al., 1998). Recent studies 
even showed that iNOS exerts an anti-apoptotic effect on the liver during experimental 
endotoxemia (Mahidhara and Billiar, 2000; Ou et al., 1997; Li and Billiar, 2000). 
Previous studies have demonstrated that NO prevents apoptosis by inhibiting 
caspase proteolytic activation as well as by directly suppressing caspase activity (Kim et 
al., 1997; Mannick et al., 1999; Rossig et al., 1999; Tenneti et a., 1997; Melino et al., 1997; 
Dimmeler et al., 1997). There were several mechanisms proposed to contribute to the anti-
apoptotic effect of NO on hepatocytes, including the suppression of activity of multiple 
caspases by nitrosylation (Kim et al., 1997)，inhibition of Bcl-2 cleavage and cytochrome c 
release (Kim et al., 1998), decreased mitochondrial formation of reactive oxygen 
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intermediates (Hakoda et al., 1999), and suppression of the induction of pro-apoptotic 
genes (Zamora et al., 2001). Some of these actions are cGMP-dependent and cGMP 
analogues suppress caspase activation, loss of mitochondrial membrane potential, and 
cytochrome c release. 
Whether NO protects cells from apoptosis or induces cell death most likely 
depends on the rate of NO formation and the prominence of caspase-3-like protease 
activation in the apoptotic process as well as other factors such as the presence of other 
radicals and antioxidants, or cell type specific factors. Apoptosis is mostly associated with 
the delivery of NO by chemical donors whereas antiapoptotic effects seem to be related to 
the endogenous production of NO by NOS. 
3.6.2 Regulation of apoptosis by cGMP 
In some cell systems, the anti-apoptotic function of NO is mediated, at least 
partially, by NO-dependent generation of intracellular cGMR For example, the protection 
of NO against apoptosis is found to be dependent on production of the secondary 
messenger cGMP in B-lymphocytes (Genaro et a., 1995)，eosinophils (Beauvais et al., 
1995), embryonic motor neuron (Estevez et al., 1998), PC12 cells (Kim et al., 1999), and 
ovarian follicles (Chun et al., 1995). However, it is unknown how cGMP prevents 
apoptosis signaling and supports survival. cGMP has been shown to up-regulate Bcl-2 
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expression in splenocytes (Genaro et a l , 1995). However, in other cell types, the 
antiapoptotic mechanism is clearly independent ofcGMP (Mannick et a., 1994) 
cGMP levels are determined by guanylyl cyclases (GCs), cGMP 
phosphodiesterases (PDEs) and cGMP export pumps (Patel et al., 1995; Jedlitschky et al., 
2000). Soluble guanylyl cyclase (sGC) is a heme-containing enzyme catalyzing the 
conversion of GTP to cGMP in cells and exists in both particulate and soluble fractions 
(Waldman and Murad, 1987). sGC activation can be achieved by the binding of NO or 
compounds such as azide or hydroxylamine to heme. The membrane-bound, particulate 
GCs (pGCs) are activated by the binding of extracellular natriuretic peptides, guanylin or 
the heat-stable enterotoxin of E. coli (ST). The effects of sGC on the survival of 
mammalian cells appear to be different in different cell types and different experimental 
conditions. For example, activation of sGC has been shown to exert pro-apoptotic effects 
in some cells types, including cardiomyocytes (Taimor et aL, 2000), colon tumor cells 
(Thompson et al., 2000) and vascular smooth muscle cells (Pollman et al., 1996). However, 
there were also reports showing protective effects of sGC on the survival of other types of 
cells, such as neural cells (Garthwaithe and Garthwaithe, 1998; Garthwaite et al., 1995; 
Estevez et a l , 1998; Thippeswamy and Morris, 1997; Fiscus, 2002; Fiscus et al., 2002), 
leukemia cells (Flamigni et al., 2001) and liver cells (Li et aL, 2000). 
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Cell-membrane-permeant analogues of cGMP have been widely used to elucidate 
the functional role of cGMP-dependent protein kinase (PKG) in the regulation of 
biological processes (Sekhar et al., 1992; Butt et al.，1993). PKG, a serine/threonine kinase, 
is widely expressed in mammalian cells and is activated by cGMP binding. The possible 
involvement of cGMP and PKG in apoptosis is supported by studies in rat myocytes (Wu 
et al., 1997), pancreatic P cells (Loweth et al., 1997), and endothelial cells (Suenobu et al., 
1999). PKG has recently been shown to play a role in driving exisulind-induced apoptosis 
of colon tumor cells (Thompson et al., 2000) and NO-induced apoptosis of pancreatic and 
vascular smooth muscle cells (Kockx and Knaapen, 2000). There is data showing that 
transfection of PKG increases the sensitivity of vascular smooth muscle cells to apoptosis 
inducers (Chiche et al., 1998). 
3.6.3 Regulation of apoptosis by soluble guanylyl cyclase activator 
Different NO donor compounds have been clinically used for over 100 years for the 
treatment of different vascular and heart diseases, however, these compounds carry the risk 
of generating tolerance and cross tolerance after prolonged usage (Thadani, 1996), making 
it necessary to suppress the treatment for several periods (Luke et al., 1987). A potentially 
physiologically relevant mechanism that sensitises sGC and cGMP has recently been 
described, and may represent an important new therapeutic intervention. YC-1, [3-(5'-
hydroxymethyl-2 '-furyl)-1 -benzylindazole], is a chemically synthesized compound that 
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was originally shown to directly stimulate platelet sGC activity and cGMP production and 
thereby inhibit platelet aggregation and thrombosis (Ko et al., 1994). The ability of YC-1 
to directly activate sGC，to potentiate the stimulatory actions of NO and carbon monoxide 
(CO) on sGC, and to concurrently cause a persistent elevation of cGMP through inhibition 
of cGMP breakdown makes it a potentially attractive new therapeutic agent. Since YC-1 is 
a highly effective vasodilator compound with a prolonged duration of action, the use of 
YC-1 with therapeutic purpose might avoid the problem of tolerance to NO donors. 
Furthermore, YC-1 boosts the effect of NO and its use might permit the reduction of 
nitrovasodilator dosage, avoiding the toxic effects due to high NO concentrations (Miilsch 
et al., 1997). Besides stimulating sGC, YC-1 also inhibits the activity of several PDEs (Ko 
et al., 1994; Friebe et a l , 1998; Galle et aL, 1999), thus increasing synthesis of cGMP and 
decreasing both cGMP and cAMP breakdown in different cell types (Galle et al., 1999). In 
the present study, we determined the effects of YC-1 on the apoptosis induced by serum 
deprivation in HRE-H9 cells. 
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Chapter 4: Apoptotic DNA fragmentation caused by sodium nitropmsside, a nitric 
oxide donor, in uterine epithelial cells: Ultrasensitive quantitation using 
the new capillary electrophoresis/laser-induced fluorescence (CE-LIF) 
technology 
4.1 Abstract 
Apoptotic cell death of uterine epithelial cells is thought to play an important role 
in onset of menstruation, successful implantation of embryos and development of 
endometriosis. Thus, abnormalities in uterine epithelial apoptosis may result in 
dysmenorrhea, infertility and/or endometriosis. The aim of our study was to determine the 
toxic, pro-apoptotic effects of sodium nitropmsside (SNP), a NO-releasing agent 
commonly used in research and clinical treatment, on uterine epithelial cells. These effects 
were assessed by both the conventional agarose (slab) gel electrophoresis (i.e. DNA 
laddering) and a new quantitative ultrasensitive CE-LIF technique, recently developed in 
our laboratory to accurately quantify levels of apoptotic DNA fragmentation. An 
immortalized cell line (HRE-H9 cells), originally derived from rabbit uterine epithelial 
cells, and primary cultures of mouse uterine epithelial cells were used as cell culture 
models. In addition to SNP-induced toxicity, we also determined the effects of serum 
deprivation and over-crowding culturing condition on DNA fragmentation. When HRE-H9 
cells were grown in over-crowded conditions they became apoptotic; i.e. the higher the cell 
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density, the higher the level of apoptotic DNA fragmentation. Exposure to SNP or serum 
deprivation induced apoptosis in both HRE-H9 cells and primary cultures of mouse uterine 
epithelial cells. HRE-H9 cells in serum-free medium for 24 h showed 4.6-fold higher 
levels of apoptotic DNA fragmentation compared to cells in medium with serum. SNP at 
500 and 1000 |iM (for 7 h) significantly increased apoptotic DNA fragmentation by 3.0 
and 112 fold, respectively. In primary cultures, serum deprivation and SNP (500 |LIM) 
caused 21-fold and 12.5-fold increases in apoptotic DNA fragmentation, respectively, but 
required much longer time (72 h). Our data demonstrated that SNP, serum deprivation and 
over-crowding conditions all cause elevated apoptotic DNA fragmentation in uterine 
epithelial cells, as measured by the new quantitative ultrasensitive CE-LIF technique. 
4.2 Introduction 
Apoptosis is now recognized as an important event in the development and function 
of the reproductive system (Gosden and Spear, 1997). Progressive increases in apoptosis 
occur in uterine epithelial cells during the secretory and menstrual phases of the menstrual 
cycle in humans (Tabibzadeh, 1995) and the estrous cycle in rats (Sato, et al.，1997). The 
apoptosis of uterine epithelial cells is thought to play an important role in the regulation of 
the menstruation cycle and abnormalities in the regulation of epithelial apoptosis may thus 
result in dysmenorrhea. 
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Implantation of an embryo into the wall of the uterus also involves apoptosis of 
epithelial cells. Uterine epithelial cells surrounding the embryos during implantation 
undergo apoptosis and this leads to the phagocytosis of the epithelial cells by trophoblast 
cells in mice and rats (Parr et al., 1987; Kamijo et al., 1998). Therefore, induction of 
apoptosis of endometrial epithelial cells may represent an essential cellular event for 
successful implantation. A lack of proper apoptosis of uterine epithelial cells during 
implantation is thought to be one of the causes of infertility. 
Another condition associated with abnormal apoptotic responses in uterine 
epithelial cells is endometriosis. Gebel et al., (1998) showed that spontaneous apoptosis of 
endometrial tissue is impaired in women with endometriosis. Thus, abnormal growth and 
impaired sensitivity to spontaneous apoptosis in uterine epithelial cells is thought to cause 
endometriosis. 
One of the hallmarks of apoptosis in uterine epithelial cells, like in many types of 
cells, is the activation of an endonuclease that causes intemucleosomal fragmentation of 
the genomic DNA (Rotello et al., 1989). The conventional technique for assessing 
apoptotic DNA fragmentation is agarose (slab) gel electrophoresis (i.e. DNA laddering). 
However, when using this conventional technique, a relatively large amount of DNA and 
thus a large number of cells, typically 2 to 10 million cells per sample, are needed to obtain 
clear DNA laddering on agarose gels (Fiscus, 2002; Fiscus et al., 2002). A new technology 
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has recently emerged using capillary electrophoresis (CE) to separate and identify the 
apoptotic fragments of DNA in certain types of cells, e.g. thymocytes (Evans et al” 1995), 
hybridoma cells (Solis-Recendez et al., 1995) and leukemia/lymphoma cells (Siles et al., 
1997). Only the study by Evans et al. (1995) had utilized the new ultrasensitive detector, 
the laser-induced fluorescence detector (LIF), coupled with CE, to observe the apoptotic 
DNA fragmentation. However, the study did not attempt to quantify the levels of apoptotic 
DNA fragmentation. 
Our laboratory has further developed this CE-LIF technology, using DNA 
standards to generate standard curves for accurately quantifying the levels of apoptotic 
DNA fragmentation in two types of cells: epithelial (HRE-H9) cells (Fiscus et al., 2001a) 
and neural (NlE-115, NG108-15 and PC 12) cells (Fiscus et al., 2001b; Fiscus, 2002; 
Fiscus et al., 2002). With the new CE-LIF technology, apoptotic DNA fragmentation can 
now be assessed with a sensitivity that is > 1,000-fold better than that of the conventional 
agarose gel electrophoresis technique. 
Nitric oxide (NO) can cause either toxic effects, leading to apoptotic and/or 
necrotic cell death, or protective (anti-apoptotic) effects, depending on the type of cells 
studied, on the concentration of the NO donor used and on other experimental conditions, 
such as the levels of superoxide anion, which combines with NO to form the very toxic 
peroxynitrite (Fiscus, 2002; Fiscus et al., 2002). For example, NO has been shown to 
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induce apoptosis in the pancreatic B-cell line HIT-T15 (Loweth et al., 1997), endothelial 
cells (Suenobu et a l , 1999) and cardiomyocyte (Shimojo et al., 1999; Arstall et al., 1999). 
In contrast, NO has anti-apoptotic effects in lymphocytes (Genaro et al., 1995), PC12 cells 
(Kim et al., 1999) and primary dorsal root ganglion neurons (Thippeswamy et al., 2001). 
Data from two recent studies have suggested that NO may have toxic effects in 
uterine epithelial cells, leading to increased apoptosis. First, isolated slices of human 
endometrial tissue show increased apoptosis (assessed by TUNEL staining) when 
incubated in vitro with L-arginine, the precursor of NO biosynthesis (Castro et al., 2002). 
Second, a human endometrial carcinoma cell line (RL95-2 cells), when exposed to sodium 
nitropmsside (SNP), a NO donor, showed decreased cell survival, assessed by the MTT 
technique, and increased caspase-3 activity, an indicator of apoptosis (Li et al., 2001b). 
However, to our knowledge, there have been no previous reports providing an accurate 
measure of apoptotic DNA fragmentation to quantify the pro-apoptotic effects of NO in 
uterine epithelial cells. Furthermore, previous reports have not used primary cultures of 
uterine epithelial cells, presumably because of the limited number of cells that can be 
obtained in primary cultures and the lack of sensitivity of the previous techniques for 
determining apoptotic DNA fragmentation. 
The purpose of the present study was to use the new quantitative ultrasensitive CE-
LIF technique to accurately quantify the effects of the NO donor SNP on apoptotic DNA 
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fragmentation in uterine epithelial cells, using both a rabbit immortalized epithelial cell 
line (HRE-H9 cells) and primary cultures of mouse uterine epithelial cells. SNP was 
selected because it is one of the most commonly used NO donors for both research 
purposes and clinical treatments (Hardman and Limbird, 2001). In experiments with HRE-
H9 cells, we also used the conventional agarose gel electrophoresis technique for 
comparison. The effects of serum deprivation and overcrowding culturing condition were 
also investigated to determine their effects on the levels of apoptotic DNA fragmentation 
in uterine epithelial cells. 
4.3 Results 
Apoptotic DNA fragmentation induced by overcrowding conditions in HRE-H9 cells 
Under normal culturing conditions, the HRE-H9 cells showed a large flat morphology 
and were attached to the culture dishes firmly. However, as the culturing time increased, 
the cells began to detach from the culture dishes as observed under the microscope. The 
HRE-H9 cells were assessed for the presence of apoptotic DNA fragmentation at the 
different culturing times. The HRE-H9 cells were incubated in medium with 4% fetal 
bovine serum for 24, 36, 48, 60 and 72 h. Cells in the dish for 48, 60 and 72 h showed 
increasing intemucleosomal DNA fragmentation on agarose gels, which indicated the 
onset of apoptosis of the cells, starting at about 48 h (Fig. 4.1). As the culturing time 
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increased, cells grew more densely and the levels of apoptotic DNA fragmentation clearly 
increased. Thus, overcrowding conditions had induced apoptosis in the HRE-H9 cell. 
Apoptotic DNA fragmentation induced by serum deprivation in HRE-H9 cells 
Under normal culture conditions, HRE-H9 cells were grown in DMEM with 4 % fetal 
bovine serum (FBS). Cells grown in medium with 4% FBS showed a large flat 
morphology and were attached to the culture dishes firmly (at least for the first 48 h). 
However, when the HRE-H9 cells were incubated in medium without FBS for 24 h, they 
showed an increased number of cells with rounded morphology and intemucleosomal 
DNA fragmentation (assessed by agarose gels), which indicated the increased presence of 
apoptosis (Fig. 4.2). The effect of serum deprivation for 24 h was then examined by the 
new quantitative CE-LIF technique. The amounts of the DNA fragments were clearly 
larger in the samples from cells incubated in medium without FBS compared with cells 
incubated in medium with 4% FBS (Fig. 4.3). The peak at 20 min, representing the 540 bp 
DNA fragment from apoptotic cells, was used to calculate the amount of DNA. The 
amounts of fragmented DNA were significantly (P < 0.01) higher in cells in serum-free 
medium than in cells in medium with 4% serum (Fig. 4.4). Cells in serum-free medium 
had a 4.6-fold higher level of apoptotic DNA fragmentation than cells in medium with 4% 
FBS (Fig. 4.4). 
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Apoptotic DNA fragmentation induced by the NO donor SNP in HRE-H9 cells 
SNP, when added at higher concentrations (e.g. 500 [iM and above), caused 
detachment of some of the HRE-H9 cells from the culture dish, as observed under the 
microscope. At the concentrations (0, 62.5, 125, 250, 500 and 1000 [xM) used, SNP caused 
detectible fragmentation of DNA only at 500 and 1000 )iM, when assessed by agarose gels 
(Fig. 4.5). The dose-dependent effect of SNP on the induction of apoptosis in HRE-H9 
cells was then analyzed using the quantitative CE-LIF technique. SNP dose-dependently 
increased the levels of apoptotic DNA fragmentation in HRE-H9 cells, in some cases 
starting at a concentration of 250 |LIM (Fig. 4.6). The peak at 21 min, representing the 540 
bp DNA fragment from apoptotic cells, was used to calculate the amount of DNA. SNP at 
250, 500 and 1000 luM caused 1.5-，3.0- and 112-fold increases in the levels of apoptotic 
DNA fragmentation, respectively, compared to the controls (Fig. 4.7). 
Apoptotic DNA fragmentation induced by serum deprivation or exposure to SNP in 
primary cultures of mouse uterine epithelial cells 
The CE-LIF electropherograms in Figure 4.8 show the effects of serum deprivation 
and exposure to SNP on apoptotic DNA fragmentation in primary cultures of mouse 
uterine epithelial cells. The cells were incubated for 72 h in medium with 10% FBS (A), 
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medium deprived of serum (B) or medium with 10% FBS plus SNP (500 [iM) (C). Serum 
deprivation and SNP increased the levels of apoptotic DNA fragmentation (using the peak 
representing the 360 bp apoptotic DNA fragment) in the primary uterine epithelial cells by 
21 and 12.5 fold, respectively. However, the time of incubation that was needed to induce 
apoptosis in the primary cultures was much longer than that needed for the HRE-H9 cells. 
Instead of 24 h in serum-deprivation experiments and 7 h in SNP-exposure experiment 
needed for induction of apoptosis in HRE-H9 cells, 72 h was needed to induce the 




The present study has used the new quantitative ultrasensitive CE-LIF technology 
to accurately quantify the toxic, pro-apoptotic effects of the NO donor SNP in uterine 
epithelial cells. SNP is a pharmaceutical agent that is often used to treat severe 
hypertension as well as certain heart conditions, such as congestive heart failure and 
myocardial infarction (Hardman and Limbird, 2001). Furthermore, SNP is one of the most 
commonly used NO-releasing agents in scientific experiments investigating the 
pharmacologic or toxic effects of NO. The present study shows the toxic, pro-apoptotic 
effects of SNP in both an immortalized uterine epithelial cell line, HRE-H9 cells, and 
primary cultures of mouse uterine epithelial cells. The use of primary cells, isolated from 
mice, was especially important, because it establishes the capability of studying apoptotic 
DNA fragmentation in phenotypically-normal cells and provides evidence that future 
studies with primary cells isolated from genetically-modified mice will be technically 
possible. In addition to SNP-induced apoptosis, we have also shown that other factors, 
such as serum deprivation and overcrowded culturing conditions, increase the apoptotic 
DNA fragmentation in uterine epithelial cells. 
Nitric oxide has been reported to have pro-apoptotic effects in various cells, such as 
macrophages (Albina et al., 1993; Sarih et al., 1993), human articular chondrocytes 
(Blanco et al., 1995), osteoblasts (Chen et al., 2002), spiral ganglion cells (Pai et al., 1998), 
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mesangial cells (Sandau et al., 1997), neuroblastoma cells (Yamada et al., 1996) and 
smooth muscle cells (Nishio et al., 1996). Several mechanisms have been proposed to 
explain the pro-apoptotic effects of NO. One proposed mechanism is that NO, if present at 
sufficiently high concentrations, reacts rapidly with superoxide anion to form the highly 
toxic peroxynitrite (ONOO ) (Estevez et al., 1995; for reviews, see Fiscus, 2002 and Fiscus 
et al., 2002). Previous reports have shown that peroxynitrite induces both necrosis and 
apoptosis, depending on its concentration and the conditions of the experiments (Estevez et 
al., 1995; Salgo et al., 1995; Lin et al., 1995). Both NO and ONOO'were demonstrated to 
cause apoptotic DNA fragmentation in vascular smooth muscle cells (O'Connor et al., 
1997). 
There are also reports showing the opposite effect of NO in the regulation of 
apoptosis. For example, NO was shown to inhibit apoptosis in gastric mucous cells (Potter 
and Hanson, 2000) and to protect certain cells from various types of apoptotic stimuli, such 
as serum deprivation-induced apoptosis in PC 12 cells (Kim et al., 1999), 
lipopolysaccharide-induced apoptosis in pulmonary artery endothelial cells (Ceneviva et 
al., 1998) and stretch-induced apoptosis in alveolar type II epithelial cells (Edwards et al., 
2000). Therefore, NO can act as both a pro-apoptotic agent and an anti-apoptotic agent and 
seems to have the ability to either initiate or block apoptosis, depending on the type of cells 
studied, the concentrations of NO used or other conditions of the experiment (Fiscus, 2002; 
Fiscus et al., 2002). 
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Both the endothelial form of NO synthase (eNOS) and the inducible form o fNOS 
(iNOS) are expressed in the uterus (Jaing et al., 1996; Telfer et a., 1997; Buhimschi et a l , 
1996). During the menstruation cycle, the endometrium shows a gradual increase in the 
expression of iNOS as the cycle progresses from the proliferative phase towards the 
secretory phase (Tschugguel et al., 1999). In addition, embryos at an early stage of 
development can generate NO and this NO production seems to be required for normal 
embryonic development (Gouge et al., 1998). Although the exact biological function of 
this enhanced NO production is not clearly understood, it has been proposed that NO-
induced apoptosis of uterine epithelial cells may be an important step in the progression of 
the menstrual cycle (Castro et al., 2002). Furthermore, NO-mediated induction of apoptosis 
in uterine epithelial cells has been proposed to participate in the successful implantation of 
an embryo (Li et a l , 2001b). Apoptosis caused by exposure to a NO donor, like that shown 
in the present study, may alter the normal regulation of menstruation and embryonic 
implantation. 
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The data of the present study show that the addition of exogenous NO, provided by 
the NO donor SNP, elevates apoptotic DNA fragmentation in both immortalized uterine 
epithelial cells and primary cultures of mouse epithelial cells, determined by the new 
quantitative ultrasensitive CE-LIF technology. The present study also shows that 
overcrowded conditions and serum-deprivation cause apoptotic DNA fragmentation in the 
uterine epithelial cells. Initially, we had found that the larger the number of HRE-H9 cells 
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that had been seeded in the culture dishes, the higher the levels of apoptotic DNA 
fragmentation, measured 24 h after seeding (data not shown). Then, we found that seeding 
a certain number of cells (5 million cells per 100 mm culture dish), followed by incubation 
for 24 to 72 h, caused a progressive increase in the levels of apoptosis. This new 
information will help in establishing the appropriate culturing conditions for the 
assessments of apoptosis in uterine epithelial cells in future experiments. 
Our laboratory had previous utilized the CE-LIF technique to determine if serum 
deprivation in HRE-H9 cells results in apoptosis. We had shown that serum deprivation 
causes time-dependent increases in the apoptotic DNA fragmentation in HRE-H9 cells, 
beginning at 5 h and progressively increasing at 7 and 24 h (Fiscus et al., 2001a). The 
present study has found a 4.6-fold increase in the 540 bp apoptotic DNA fragments in 
HRE-H9 cells without serum for 24 h compared to cells with serum. The primary cultures 
of mouse uterine epithelial cells showed a 21-fold increase in apoptotic DNA 
fragmentation following serum deprivation. However, the time needed for the induction of 
apoptosis in the primary cultures was much longer than in the HRE-H9 cell line. For 
example, 72 h of incubation in serum-free medium was needed to induce apoptosis in the 
primary uterine epithelial cells, compared with only 5 h in HRE-H9 cells (Fiscus et al., 
2001a). To our knowledge, the present study is the first to report the effects of serum 
deprivation and a NO donor on apoptosis in primary cultures of uterine epithelial cells. 
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In summary, the present study has used the new ultrasensitive CE-LIF technology 
to accurately quantify the levels of apoptotic DNA fragmentation caused by the NO donor 
SNP and by serum deprivation in both rabbit immortalized uterine epithelial cells, HRE-
H9 cells, and primary cultures of mouse uterine epithelial cells. Because of the exceptional 
sensitivity of the CE-LIF technique, only a few thousand cells were needed to measure the 
apoptotic DNA fragmentation, thus allowing for the first time the accurate quantitation of 
apoptotic DNA fragmentation in a limited number of cells in primary cultures. 
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FIG. 4.1. DNA laddering on an agarose gel of DNA samples from HRE-
H9 cells grown for 24 to 72 h in medium with serum. Each lane 
represents a sample from cells grown in a 100 mm culture dish. Samples 
in all lanes are from cells of the same passage in the same experiment. 
The image is representative of 3 experiments, all showing similar results. 
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FIG 4 2 DNA laddering on an agarose gel of DNA samples from HRE-H9 cells 
with and without serum for 24 h. The second and third lanes represent samples 
(from two separate experiments) of cells incubated in DMEM culture medmm 
^i th 4 % serum in 100 mm culture dishes. The fourth and fifth lanes represent 
samples (from two separate expe匪ents) of cells incubated m DMEM culture 
m e c L n without serum in 100 mm culture dishes. The image is representative of 
5 experiments, all showing similar results. 
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FIG 4 3 CE-LIF electropherograms of the apoptotic DNA fragments isolated from 
the HRE-H9 cells with serum (A) and without serum (B) for 24 h. Each 
electropherogram represents a sample from cells incubated in a well of a 6-well 
culture plate. Samples in both electropherograms are from cells of the same passage 
in the same experiment. The electropherograms are representative of 5 experiments, 
all with similar results. Note the large increase in apoptotic DNA fragmentation m 
the sample without serum for 24 h. 
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FIG. 4.4. The combined data of 5 experiments showing the amounts of the 540 bp 
fragment of DNA in samples from HRE-H9 cells with and without serum. Data 
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FIG. 4.5. DNA laddering on an agarose gel of DNA samples from HRE-H9 
cells exposed to sodium nitroprusside (SNP) at the indicated concentrations. 
Cells were treated with SNP for 7 h. Each lane represents a sample from cells 
in a 100 mm culture dish. Samples in all lanes are from cells of the same 
passage in the same experiment. The image is representative of 5 experiments, 
all with similar results. 
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FIG 4 6 CE-LIF electropherograms of the apoptotic DNA fragments isolated from the 
HRE-H9 cells exposed to sodium nitroprusside (SNP) at various concentrations (A: 0 |aM; 
B. 62 5 uM- C. 125 ^iM; D: 250 ^iM; E: 500 ^iM; F: 1000 ^iM). Cells were treated with 
SNP for 7 h. Each electrophero gram represents a sample from cells incubated in a well m 
a 6-well culture plate. Samples in all electropherograms are from cells of the same 
passage in the same experiment. The electropherograms are representative of 6 
experiments, all with similar results. SNP at 500 and 1000 ^iM had caused noticeable 
increases in apoptotic DNA fragmentation in all 6 experiments. However, SNP at 250 ^M 
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FIG 4 7 The combined data of 6 experiments, showing the amount of the 540 bp 
fragment of DNA measured in each of the electropherograms, represented m Fig 





FIG 4 8 CE-LIF electropherograms of the apoptotic DNA fragments isolated from 
the primary cultures of mouse uterine epithelial cells, under control (i.e plus serum) 
conditions for 72 h (A), without serum for 72 h (B) or exposed to sodium 
nitropmsside (SNP, 500 一） m the presence of serum for � �^ j C ) E 二 
electmpherogram represents a sample from cells incubated in a well of a 6-wd 
culture plate. The electropherograms are representative of 3 experiments, all 
showing similar results. 
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Chapter 5: Guanylyl-cyclase inhibitors NS2028 and ODQ and protein kinase G (PKG) 
inhibitor KT5823 trigger apoptotic DNA fragmentation in an 
immortalized uterine epithelial cells: anti-apoptotic effects of basal 
cGMP/PKG 
5.1 Abstract 
The present study determined involvement of the cGMP/protein kinase G (PKG) 
signaling pathway in the development of apoptosis in an immortalized uterine epithelial 
cell line, HRE-H9 cells, using two soluble guanylyl cyclase (sGC) inhibitors, NS2028 and 
ODQ, and a protein kinase G (PKG) inhibitor, KT5823. Both NS2028 and ODQ 
significantly (P<0.05) increased apoptotic DNA fragmentation in unstressed (with serum 
present) HRE-H9 cells, measured by a new quantitative ultrasensitive technique using 
capillary electrophoresis with laser-induced fluorescent detector (CE-LIF), recently 
developed in our laboratory. NS2028 at 10 and 100 |LIM caused 2.4- and 3.5-fold increases 
and ODQ (40 jiM) caused 9.9-fold increase in apoptotic DNA fragmentation, suggesting 
that lowering the basal cGMP levels causes spontaneous activation of a pro-apoptotic 
pathway. A cell-permeable cGMP analogue, 8-Br-cGMP (100 _ and 1 mM), which 
directly activates PKG, prevented ODQ-induced apoptosis by 42% and 81%, respectively, 
indicating that replacement of the lowered cGMP with a direct PKG activator can prevent 
the apoptosis. Western blot analysis, using an antibody specific for PKG type I (PKG-I), 
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indicated that HRE-H9 cells express PKG-I at moderate levels. Inhibiting basal PKG 
activity with KT5823 (100 nM and 1 ^iM) significantly (P<0.05) increased apoptotic DNA 
fragmentation in HRE-H9 cells by 5.9 and 9.8 fold, respectively. Overall, the data show 
that inhibitors of basal sGC and PKG activities in unstressed immortalized uterine 
epithelial cells cause apoptotic DNA fragmentation, suggesting that normal basal levels of 
cGMP and PKG activity may be necessary to prevent spontaneous development of 
apoptosis in these cells. 
5.2 Introduction 
Apoptosis is important to many physiologic/pathgologic processes. Dysregulated 
apoptosis may contribute to the pathogenesis of a number of diseases, including cancer 
(Liebermann et al., 1995), autoimmune diseases (Reap et al., 1995), AIDS (acquired 
immunodeficiency syndrome) (Ameisen, 1992), neurodegenerative disorders (Estevez et 
al., 1998; Fiscus and Ming, 2000; Fiscus, 2002) and leukemia (Meinhardt et al., 1999; 
Kolb, 2000). Altering the apoptotic threshold may change the natural progression of some 
of these diseases. For example, the effectiveness of chemotherapeutic drugs for various 
cancers may depend on the ability of these agents to induce apoptosis preferentially in the 
cancer cells (Li et al., 2000b). 
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In the female reproductive system, apoptosis of the uterine epithelial cells is now 
recognized to be an important step in the normal onset of menstruation (Tabibzadeh, 1995; 
Sato, et al, 1997; Tao, 1997; Toki, 1998) as well as the normal implantation of an embryo 
into the uterine wall during pregnancy (Parr et al., 1987; Kamijo et al., 1998; Galan et al., 
2000). Dysregulation of uterine epithelial apoptosis may thus lead to dysmenorrhea and 
infertility. Abnormal apoptosis of uterine epithelial cells is also thought to contribute to the 
pathogenesis of endometriosis (Gebel et al., 1998; Garcia-Velasco et al., 2002). Therefore, 
uterine epithelial apoptosis is an important part of the physiologic/pathologic regulation of 
the female reproductive system. 
Nitric oxide (NO) is known to be involved in the regulation of apoptosis, both as an 
anti-apoptotic factor and as a pro-apoptotic factor, depending on the type of cells, the 
concentrations of NO and the experimental conditions (for reviews, see Fiscus, 2002; 
Fiscus et al., 2002). Previously, NO had been shown to cause toxicity and cell death (both 
apoptosis and necrosis), notably in the central and peripheral nervous systems, where NO 
is thought to contribute to the neuronal damage of various neurodegenerative diseases, 
including amyotrophic lateral sclerosis (ALS) (Beckman and Koppenol, 1996)， 
Alzheimer's disease and Parkinson's disease (Fiscus and Ming, 2000; Fiscus, 2002; Fiscus 
et al., 2002). Recently, NO has been shown to cause apoptosis in a human endometrial 
carcinoma cell line, RL95-2 cells, and this type of NO-induced apoptosis has been 
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proposed to be responsible for, at least in part, the apoptosis of uterine epithelial cells that 
occurs during menstruation and embryonic implantation (Li et al., 2001b). 
NO also exerts anti-apoptotic effects in certain cells, either through mechanisms 
involving activation of soluble guanylate cyclase (sGC) and subsequent elevation of cGMP 
levels or, in some cells, through mechanisms independent of sGC (Kim et al., 1997; Kolb， 
2000; Fiscus, 2002; Fiscus et al., 2002). Endogenous NO synthesis or exposure to low 
levels of NO donors has now been shown to inhibit apoptosis in a number of different 
kinds of cells, including B lymphocytes (Mannick et al., 1994; Genaro et al., 1995), 
eosinophils (Beauvais et al., 1995), ovarian follicles (Chun et al., 1995), endothelial cells 
(Dimmeler et al., 1997) and rat cerebellar granule cells and cortical cells (Pantazis et al., 
1998; Femandez-Tome et al., 1999). In some of these cells, the anti-apoptotic actions of 
NO were shown to be dependent on the cGMP elevations (Beauvais et al., 1995; Chun et 
al., 1995; Genaro et al., 1995), while in other cells, the anti-apoptotic mechanism of NO 
was independent of cGMP (Mannick et al., 1994). 
Previously, data from the laboratory of Professor Fiscus had shown that two 
natriuretic peptides, atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), 
which activate particulate guanylyl cyclase (pGC) and cause prolonged elevations of 
cGMP levels, are potent and effective inhibitors of apoptotic cell death caused by serum-
deprivation-induced stress in PC 12 cells, resulting in a significant prolongation of cell 
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survival (Fiscus et a l , 2001b). Furthermore, 8-Br-cGMP, a cell-permeable analog of 
cGMP that directly activates protein kinase G (PKG), was also found to inhibit apoptosis 
in stressed PC 12 cells. Thus, cGMP and PKG appear to be intimately involved in the 
prevention of apoptosis and the prolongation of cell survival, at least in certain types of 
cells, like PC 12 cells. Many other neural cells have also been found to possess a similar 
anti-apoptotic/pro-survival pathway involving the cGMP/PKG signaling pathway (for 
reviews, see Fiscus, 2002; Fiscus et al., 2002). Furthermore, in some neural cells, such as 
NlE-115 and NG108-15 cells, even the basal levels of cGMP and basal activity of PKG 
appear to be sufficient to cause anti-apoptotic effects, protecting these cells against a 
spontaneous development of apoptosis (Yuen and Fiscus, 2001; Fiscus, 2002). 
To our knowledge, no previous report has shown the involvement of cGMP and 
PKG in the regulation of apoptosis in uterine epithelial cells. Furthermore, no previous 
report has focused on the potential involvement of basal cGMP levels and basal PKG 
activity in protecting epithelial and/or reproductive cells against spontaneous development 
of apoptosis. The present study was designed to determine if basal cGMP levels and basal 
PKG activity are involved in the control of apoptosis in uterine epithelial cells, using an 
immortalized cell line, the HRE-H9 cells. We determined the levels of apoptosis in these 
cells by quantifying the intemucleosomal fragmentation of the genomic DNA, a hallmark 
of apoptosis in uterine epithelial cells (Fiscus et al., 2001a). The apoptotic DNA 
fragmentation was measured by a new quantitative ultrasensitive technique using capillary 
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electrophoresis with laser-induced fluorescence detector (CE-LIF), recently developed in 
our laboratory (Fiscus et al., 2001a; Fiscus et al , 2001b; Fiscus, 2002; Fiscus et al., 2002). 
We used two sGC inhibitors, 4H-8bromo-l, 2,4-oxadiazola (3,4-d) benz (b-1,4) 
oxazin-l-one (NS2028) and 1H-[1,2,4] oxadiazolo [4,3, -a] quinoxalin-1-one (ODQ), to 
determine if basal sGC activity and basal levels of cGMP are involved in regulating 
apoptosis in uterine epithelial cells. The present study shows that both NS2028 and ODQ 
cause significant increases in the levels of apoptotic DNA fragmentation in the HRE-H9 
cells. Some of the ODQ-treated cells were further treated with 8-Br-cGMP to determine if 
replacement of cGMP with a cGMP analog can relieve the pro-apoptotic effects induced 
by ODQ. Because of the potential involvement of PKG in uterine epithelial cells, the 
present study also determined if HRE-H9 cells express PKG, using Western blot analysis, 
and if basal activity of PKG regulates apoptosis in these cells. The selective PKG inhibitor 
KT5823 was used to inhibit the intracellular activity of PKG in unstressed HRE-H9 cells. 
Like the sGC inhibitors NS2028 and ODQ, the PKG inhibitor KT5823 also caused 
significant increases in the levels of apoptotic DNA fragmentation. 
Preliminary data of this project, showing pro-apoptotic effects of ODQ and 




Apoptotic DNA fragmentation induced by the sGC inhibitors NS2028 and ODQ in 
unstressed HRE-H9 cells 
To examine whether basal levels of sGC activity and basal levels of cGMP are 
involved in regulating the apoptosis of uterine epithelial cells, the HRE-H9 cells were 
incubated in the presence or absence of NS2028 or ODQ, two potent and selective 
inhibitors of sGC (Morro et al., 1996; Mulsch et al., 1997; Olesen et al., 1998). All 
experiments were conducted using unstressed cells (i.e. cells incubated in normal medium 
containing serum). Exposure of HRE-H9 cells to NS2028 for 24 h caused dose-dependent 
increases in DNA fragmentation, measured by CE-LIF (Figure 5.1). Figure 5.2 shows that 
1 iiM NS2028 did not have a significant effect on apoptosis, but NS2028 at 10 and 100 juM 
significantly increased apoptotic DNA fragmentation in HRE-H9 cells, as compared to the 
controls (P<0.05; n=3). NS2028 at 10 and 100 |LIM caused 2.4- and 3.5-fold increases in 
DNA fragmentation (Figure 5.2). 
Previous studies from our laboratory had shown that ODQ (40 ]iM, 24 h), by itself, 
lowers basal levels of cGMP to one-fifth of the normal levels and triggers the onset of 
apoptosis in two neural cell lines, NG108-15 (Yuen and Fiscus, 2001) and NIE-115 (Fiscus, 
2002). In the present study, we found that ODQ (40 24 h) increased the apoptotic 
DNA fragmentation in HRE-H9 cells, analyzed by both agarose gels (Figure 5.3) and CE-
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LIF (Figure 5.4). ODQ (40 \iM) clearly increased the levels of apoptotic DNA 
fragmentation in both agarose gels and CE-LIF. Figure 5.5 shows the combination of data 
from 5 experiments using CE-LIF, showing that ODQ (40 jiM, 24 h) had significantly 
increased DNA fragmentation by 9.9 fold in HRE-H9 cells as compared with the controls 
(P<0.05; n=5). Therefore, both NS2028 and ODQ can significantly and substantially 
induce apoptosis in unstressed HRE-H9 cells. The data suggest that cGMP at basal levels 
may be necessary to prevent spontaneous development of apoptosis in these cells. 
The cGMP analogue 8-Br-cGMP prevented the ODQ-induced apoptosis 
To test whether the reduction in basal cGMP levels caused by ODQ was 
responsible for the induction of apoptosis, we determined if replacing the cGMP with a 
cell-permeable analogue of cGMP, 8-Br-cGMP, could prevent ODQ-induced apoptosis. 8-
Br-cGMP at 100 |LIM and 1 mM substantially decreased the apoptotic DNA fragmentation 
caused by ODQ, as determined by both agarose gels (Figure 5.6) and CE-LIF (Figure 5.7). 
Figure 5.8 shows the combined data of 5 experiments using CE-LIF, indicating that 8-Br-
cGMP (100 |LIM and 1 mM) caused 42 % and 81 % inhibition of the ODQ-induced DNA 
fragmentation, respectively. 8-Br-cGMP (100 [iM and 1 mM), by itself, had no significant 
effect on the levels of apoptosis (Figure 5.8). 
81 
Protein expression levels of PKG in HRE-H9 cells. 
HRE-H9 cells were analyzed for the presence of PKG protein using Western blot 
analysis. The primary antibody recognized both the type l a and type 1(3 forms of PKG. 
Figure 5.9 show the relative levels of PKG-Ia/p expression in HRE-H9 cells, compared to 
expression levels in three other cells commonly used in our laboratory (Fiscus et al., 2001b; 
Fiscus, 2002; Fiscus et al., 2002). Whereas PC 12 cells showed barely detectable levels of 
PKG, NG108-15 andNlE-115 cells had high levels of PKG expression. The HRE-H9 cells 
had intermediate levels of PKG expression. Because some cells, such as vascular smooth 
muscle cells (Lincoln and Comwell, 1993) and PC 12 cells (present study, Figure 5.9) tend 
to lose their expression of PKG during passaging, we also tested if the levels of PKG 
expression in HRE-H9 cells were altered during passaging. Figure 5.9 shows that PKG 
levels are expressed at moderate levels in all HRE-H9 cells at the three different passages 
tested. Thus, there was no indication that PKG levels are lost or reduced during passaging 
in the HRE-H9 cells. 
Apoptotic DNA fragmentation induced by the PKG inhibitor KT5823 in unstressed 
HRE-H9 cells 
We suspected that the anti-apoptotic effects of cGMP (at basal levels) were 
mediated by partial activation of PKG (i.e. basal PKG activity) in HRE-H9 cells. To test 
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this，we used a potent and highly selective PKG inhibitor, KT5823. Exposure of HRE-H9 
cells to KT5823 in a wide range of concentrations for 24 h caused dose-dependent 
increases in apoptotic DNA fragmentation, measured by CE-LIF (Figure 5.10). Because 
normal media (with serum) was used, the HRE-H9 cells were under unstressed conditions 
(except for the exposure to KT5823). While KT5823 at 1 nM and 10 nM did not affect the 
levels of apoptotic DNA fragmentation, KT5823 at 100 nM and 1 |LIM (concentrations 
expected to selectively inhibit PKG; Ki = 234 nM, Calbiochem catalog 2003/2004) 
substantially increased DNA fragmentation, compared to controls (Figure 5.10). KT5823 
at 100 nM and 1 |LIM caused 5.9- and 9.8-fold increases in the DNA fragmentation levels, 
respectively (Figure 5.11). The statistical significance of these effects was found to be very 
high (P<0.001)，due to the large pro-apoptotic effects of this PKG inhibitor. The data 
suggest that the low-level activation of PKG that occurs under normal culturing conditions, 
presumably because of the basal cGMP levels, appears to play an essential role in 
preventing spontaneous development of apoptosis in unstressed HRE-H9 cells. 
5.4 Discussion 
The present study demonstrates that two sGC inhbitiors, NS2028 and ODQ, and a 
PKG inhibitor, KT2823, all cause induction of apoptotic DNA fragmentation in the HRE-
H9 immortalized uterine epithelial cells. Because the induction of apoptosis occurred at 
concentrations of the inhibitors that would be expected to cause specific inhibition of sGC 
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or PKG, the data suggest that the basal levels of sGC and PKG activity may be essential to 
prevent spontaneous development of apoptosis in these cells. Furthermore, the present data 
show that addition of the cGMP analog 8-Br-cGMP, a cell-permeable direct activator of 
PKG, can prevent the apoptosis induced by ODQ. Thus, the cGMP/PKG signaling 
pathway appears to play an important role in the regulation of apoptosis in immortalized 
uterine epithelial cells. 
sGC is the main intracellular receptor for NO, whereas the particulate form of this 
enzyme (pGC) is the receptor for the natriuretic peptides ANP and BNP (Waldman and 
Murad, 1987; Fiscus, 2002). Elevations in cGMP levels are thought to mediate the anti-
apoptotic effects of NO in eosinophils (Beauvais et al., 1995), splenocytes (Genaro et al., 
1995), hepatocytes (Kim et al., 1997), rat dorsal root ganglia neurons (Thippeswamy and 
Morris, 1997), motor neurons (Estevez et al., 1998), pulmonary cells (Janssen et al., 1998), 
PC12 cells (Kim et al., 1999) and macrophages (Heinloth et al., 2002). Furthermore, our 
laboratory has shown that ANP and BNP cause anti-apoptotic and survival-prolonging 
effects in stressed PC 12 cells, which is mediated by prolonged elevations of cGMP levels 
(Fiscus et al” 2001b). The PKG activator 8-Br-cGMP also protected these cells against 
stress-induced apoptosis, suggesting that activation of PKG plays an important role in 
mediating the anti-apoptotic/pro-survival effects of cGMP in PC 12 cells. Many other 
neural cells show similar protection against apoptosis when cGMP levels are elevated or 
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PKG activity is increased (Fiscus, 2002). Thus, activation of the cGMP/PKG pathway 
appears to promote cell survival in a number of different types of cells. 
Very few reports, however, have focused on the potential involvement of basal 
cGMP levels or basal PKG activity in the regulation of cell survival. In 1988, Garthwaithe 
and Garthwaite showed that exposure of young rat cerebellar slices to a sGC inhibitor, 
methylene blue, caused progressive destruction of differentiating neurons, and that co-
administration of a cGMP analog protected against this destruction (Garthwaite and 
Garthwaite, 1988), suggesting basal cGMP may have neuroprotective effects. However, 
because of the known toxic effects of methylene blue (e.g. generation of superoxide) 
(Fiscus, 2002), it was not clear whether the destructive effects were caused by inhibition of 
sGC (and subsequent lowering of cGMP levels) or by the toxic effects of methylene blue. 
More recent experiments using a specific sGC inhibitor, ODQ, showed reduced survival of 
rat dorsal root ganglion neurons (Thippeswamy and Morris, 1997) and rat motor neurons 
(Estevez et al., 1998). Inhibition of sGC with ODQ was also shown to decrease the 
survival and activate a pro-apoptotic pathway in L1210 leukemia cells (Flamigni et al., 
2001). Recently, we have shown that inhibition of sGC with ODQ lowers basal cGMP 
levels to 1/5 of normal levels and causes the development of apoptosis in two established 
neural cell lines, NlE-115 and NG108-15 cells (Yuen and Fiscus, 2001; Fiscus, 2002). 
These data suggest that basal sGC activity and basal cGMP levels are involved in 
protecting neural and leukemia cells against spontaneous development of apoptosis. 
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The present study, showing that two sGC inhibitors, NS2028 and ODQ, both cause 
apoptotic DNA fragmentation in uterine epithelial cells, suggest that basal sGC activity 
and basal cGMP levels protect these cells against spontaneous development of apoptosis. 
Unlike other so-called sGC inhibitors (e.g. LY83583 and methylene blue), which are not 
potent inhibitors of sGC and have many other biological actions, ODQ has been shown to 
be a potent and selective inhibitor of sGC (Garthwaite et al., 1995). ODQ has been shown 
to inhibit cGMP elevations induced by a NO donors in human platelets and rat vascular 
smooth muscle cells (Moro et al., 1996). Our laboratory has recently shown that ODQ, 
when used as 40 |JM, the concentration used in the present study, effectively lowers basal 
cellular levels of cGMP to 1/5 of normal levels (Yuen and Fiscus, 2001; Fiscus, 2002). 
NS2028 has been shown to selectively block both basal activity of sGC and NO-induced 
activition of sGC (Mulsch et al., 1997; Olesen et al., 1998). The present data thus provide 
additional evidence that basal sGC activity and basal cGMP levels have anti-apoptotic 
effects, and show, for the first time, that this cellular mechanism may be essential for 
protecting against spontaneous development of apoptosis in uterine epithelial cells. 
Several downstream pathways have been proposed to mediate the anti-apoptotic 
effects of elevating cGMP levels (above the basal levels), including induction of Bcl-2 
mRNA and protein (Beauvais et al., 1995; Genaro et al., 1995), suppression of the gene 
expression of the pro-apoptotic Bcl-2-binding protein BNIP3 gene (Zamora et al., 2001), 
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prevention of cytochrome c release from the mitochondria (Kim et al., 1997; Kim et al., 
1999) and activation of c-Src and subsequent induction of tyrosine phosphorylation of Bcl-
2 (Tejedo et al., 2001). In astrocytes, the anti-apoptotic effects of cGMP elevations have 
been attributed to inhibition of the mitochondrial permeable transition pore (Takuma et al., 
2001). Further experiments with uterine epithelial cells will be needed to determine which 
signaling pathway is involved in the anti-apoptotic effects of basal sGC activity and basal 
cGMP levels in these cells. 
PKG has been shown to be activated by cGMP both in the test tube (for review, see 
Lincoln and Comwell, 1993) and in various intact mammalian tissues exposed to either 
NO (Fiscus et al., 1983; Fiscus et al., 1984) or the natriuretic peptide ANP (Fiscus et al., 
1985; Fiscus and Murad, 1988), suggesting that PKG is the major downstream target 
protein in the cGMP signal transduction pathway. Recently, the anti-apoptotic effects of 
both elevated and basal levels of cGMP have been proposed to be mediated by PKG 
activity in neural cells (for review, see Fiscus, 2002). In the present study, we found that 丨 
HRE-H9 cells express moderate levels of PKG, intermediate between the levels in other 
cells showing anti-apoptotic effects of cGMP (i.e. NG108-15 and NlE-115 cells with high 
PKG levels and PC 12 cells with low PKG levels). We also found that the PKG inhibitor 
KT5823, by itself, causes apoptosis in HRE-H9 cells. Because these pro-apoptotic effects 
of KT5823 occurred at concentrations (i.e. 100 nM and 1 |iM) that would be expected to 
selectively inhibit PKG, the data suggest that PKG activity under basal conditions (i.e. 
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without elevation of cGMP levels) is sufficient to provide continuous anti-apoptotic effects 
in HRE-H9 cells. 
In summary, the present study shows that selective inhibitors of sGC or PKG cause 
apoptosis in HRE-H9 immortalized uterine epithelial cells, suggesting that sGC and PKG 
activities under basal/unstimulated conditions may be essential to prevent spontaneous 
development of apoptosis. We found that HRE-H9 cells express PKG at moderate levels, 
which may be sufficient to provide effective, continuous anti-apoptotic effects (even at 
basal levels of cGMP), thus promoting the survival of these cells. Because of the 
importance of uterine epithelial apoptosis in normal menstruation and fertility and in the 
pathogenesis of endometriosis, the anti-apoptotic effects of the cGMP/PKG pathway 
describe in the present study may have special importance in the regulation of a number of 
female reproductive functions. 
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Figure 5.1. CE-LIF electropherograms of the apoptotic DNA fragments isolated from 
the H R E - H 9 cells exposed to NS2028 at 0 |LIM (control) (A), 1 |LIM ( B ) , 10 | I M ( C ) 
and 100 \iM (D). The exposure time in each case was 24 h. Each electropherogram 
represents a sample from cells grown in a well of a 6-well culture plate. Samples in all 
electropherograms were from cells of the same passage in the same experiment. The 
electropherogram set is representative of 3 experiments. 
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Figure 5 2 The combined data of 3 experiments showing the dose-dependency of the pro-
apoptotic effect of NS2028 (24 h). The amounts of the 540 bp DNA fragment were 
measured in samples from HRE-H9 cells in the different treatment conditions. The data 
represent the m e a L ± SEM of n二3 samples per group. *p<0.05 and **p < 0.01 comparing 
the treatment groups to the control. The number on the top of each bar indicates the fold-
increase in the amounts of DNA fragmentation compared to control 
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Figure 5 3 DNA laddering on an agarose gel of DNA samples from HRE-H9 cells 
incubated for 24 h in medium with serum (Control) and medium with serum plus 
ODQ (40 uM) Each lane represents a sample from cells in a 100 mm culture dish. 
Samples in all lanes are from cells of the same passage in the same experiment. The 
image is representative of 3 experiments. 
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Figure 5 4 CE-LIF electropherograms of the apoptotic DNA fragments isolated from 
theHRE-H9 cells exposed to ODQ. (A) Control. (B) Cells treated with ODQ (40 ^M) 
for 24 h Each electrophero gram represents a sample from cells in a well of a 6-weli 
culture plate Samples in all electrophero grams are from cells of the same passage m 
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Figure 5.5. The combined data of 5 experiments showing the pro-apoptotic effects 
of ODQ (24 h). The amount of 540 bp fragmented DNA were measured in 
samples from HRE-H9 cells in different the treatment conditions. The data 
represent means 土 SEM of n=5 samples per group. **P < 0.01 compared to the 
control. The number on the top of each bar indicates fold-increase in the amounts 
of DNA fragmentation compared to the control. 
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Figure 5 6 DNA laddering on an agarose gel of DNA samples from HRE-H9 cells 
treated with ODQ or the combination of ODQ and 8-Br-cGMP. Lane 1 represents the 
control. Lane 2 represents a sample from cells treated with ODQ (40 nM). Lane 3 
represents a sample from cells treated with ODQ (40 ^iM) together with 8-Br-cGMP 
(100 uM) Lane 4 represents a sample from cells treated with ODQ (40 ^iM) together 
U t h 8-Br-cGMP (1 mM). Each lane represents a sample from cells incubated in a 
100 mm culture dish. Samples in all lanes are from cells of the same passage in the 
same experiment. The image is representative of 3 experiments. 
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Figure 5.7. CE-LIF electropherograms of the apoptotic DNA fragments isolated from the 
HRE-H9 cells exposed to ODQ alone or with 8-Br-cGMP: (A) control, (B) cells treated 
with 40 |iM ODQ alone, (C) cells treated with 40 |LIM ODQ together with 100 |iM 8-Br-
cGMP, (D) cells treated with 40 |aM ODQ together with 1 mM 8-Br-cGMP, (E) cells 
treated with 100 |uiM 8-Br-cGMP alone, and (F) cells treated with 1 mM 8-Br-cGMP 
alone. Cells were all treated for 24 h. Each electropherogram represents a sample from 
cells incubated in a well of a 6-well culture plate. Samples in all electropherograms 
were from cells of the same passage in the same experiment. The electropherogram set is 
representative of 4 experiments. 
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Figure 5 8 The combined data of 4 experiments showing that 8-Br-cGMP can prevent the 
pro-apoptotic effects of ODQ. The amounts of the 540 bp DNA fragments were measured 
in samples from HRE-H9 cells in the different treatment conditions. The data represent the 
means ± SEM o f n = 4 samples per group. *P<0.05 and **P < 0.01, comparing the treatment 
groups to the control. ++p<0.01 and +++p<0.001, comparing the treatment groups to the 
ODQ treated group. 
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Figure 5 9 Western blot analysis of the PKG expression in HRE-H9 cells. The 
protein expression levels are compared with 3 other cell lines, known to possess a 
cGMP/PKG-mediated inhibition of apoptosis. 
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Fieure 5 10 CE-LIF electropherograms of the apoptotic DNA fragments isolated from 
the HRE-H9 cells exposed to KT5823: (A) control, (B) 1 nM KT5823, (C) 10 nM 
KT5823 (D) 100 nM KT5823, and (E) 1 一 KT5823. Cells were all treated for 24 h 
Each electropherogram represents a sample from cells incubated in a well of a 6-well 
culture plate. Samples in all electropherograms were from cells of the same passage m 
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Figure 5.11. The combined data of 5 experiments showing the dose-dependency of 
the pro-apoptotic effects of KT5823. The amounts of the 540 bp DNA fragments 
were measured in samples from HRE-H9 cells in the different treatment 
conditions. The data represent the means 土 SEM o f n = 5 samples per group. ***P 
< 0.001, comparing the treatment groups to the control. The number on the top of 
each bar indicates the fold-increase in the amounts of DNA fragmentation 
compared to the control. 
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Chapter 6: Direct, prolonged activation of soluble guanylyl cyclase by YC-1 or 
protein kinase G by cGMP analogs enhances the levels of apoptosis in 
an immortalized uterine epithelial cell line, HRE-H9 cells 
6.1 Abstract 
Abnormalities in the regulation of apoptosis of uterine epithelial cells are thought to 
contribute to dysmenorrhea, infertility and endometriosis. Previous studies have shown 
that activation of cGMP/protein kinase G (PKG) signaling pathway causes either anti-
apoptotic or pro-apoptotic effects, depending of the cell type and/or experimental 
conditions. Our previous studies with an immortalized uterine epithelial cell line, HRE-H9 
cells, showed that basal activity of soluble guanylate cyclase (sGC), responsible for 
synthesis of most of basal cGMP, and basal activity of PKG were involved in promoting 
anti-apoptotic effects. However, until now, there have been no reports about anti- or pro-
apoptotic effects caused by activating this signaling pathway above basal levels in uterine 
epithelial cells. The present study determined if activation of sGC or PKG affects serum-
deprivation-induced apoptosis in HRE-H9 cells, using a direct, non-nitric oxide activator 
of sGC, YC-1, and three direct, cell-permeable activators of PKG, 8-Br-cGMP, 8-pCPT-
cGMP and Sp-8-Br-PET-cGMPS. YC-1, 8-pCPT-cGMP and Sp-8-Br-PET-cGMPS all 
enhanced the apoptotic DNA fragmentation induced by serum deprivation, measured by a 
new quantitative, ultrasensitive technique using capillary electrophoresis with laser-
induced fluorescent detector (CE-LIF), recently developed in our laboratory. YC-1 at 100 
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|LIM induced 5.4-fold enhancement of apoptotic DNA fragmentation. Sp-8-Br-PET-cGMPS 
at 10 and 100 |LIM induced 4.9- and 12.6-fold enhancements of DNA fragmentation. 8-
pCPT-cGMP at 1 mM significantly elevated DNA fragmentation by 6.8 fold and 6.2 fold 
in cells with and without serum, respectively. In contrast, 8-Br-cGMP had no significant 
effect, presumably because of the more rapid metabolism of this cGMP analog. These data 
suggest that prolonged elevation of cGMP levels by YC-1 or prolonged activation of PKG 
by cGMP analogs enhances a pro-apoptotic pathway in serum-deprived immortalized 
uterine epithelial cells. 
6.2 Introduction 
Guanylate cylcase (GC) is an enzyme catalyzing the conversion of guanosine 
triphosphate (GTP) to cyclic guanosine monophosphate (cGMP) in cells and can exist in 
both particulate and soluble fractions (Waldman and Murad, 1987). The membrane-bound, 
particulate GCs (pGCs) are activated by the binding of extracellular natriuretic peptides, 
guanylin or the heat-stable enterotoxin of E. coli (ST), while the soluble form of GC (sGC) 
is the main intracellular receptor for nitric oxide (NO) (Waldman and Murad, 1987; 
Garbers, 1992). Cyclic GMP is recognized as an important second messenger that 
participates in the signal transduction pathways involved in the regulation of various 
physiological functions, including phototransduction in the rods and cones of the retina, 
activation and aggregation of platelets and the modulation of intracellular calcium levels in 
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vascular smooth muscle cells (Lincoln and Comwell, 1993). 
The effects of sGC on the survival of mammalian cells appear to be different in 
different cell types and different experimental conditions. For example, activation of sGC 
has been shown to exert pro-apoptotic effects in some cell types, including cardiomyocytes 
(Taimor et al., 2000), colon tumor cells (Thompson et al., 2000) and vascular smooth 
muscle cells (Pollman et al., 1996). However, there were also reports showing protective 
effects of sGC on the survival of other types of cells, such as neural cells (Garthwaite and 
Garthwaite, 1988; Estevez et al., 1998; Thippeswamy and Morris, 1997; Fiscus, 2002; 
Fiscus et a l , 2002), leukemia cells (Flamigni et a l , 2001) and liver cells (Li et al., 2000b). 
YC-1 (3-(5' -hydroxymethyl-2‘-furyl)-1 -benzylindazole) has been described as a 
NO-independent, direct activator ofsGC (Ko et al., 1994). YC-1 increased cGMP levels by 
a direct activation of sGC in human platelet homogenate (Wu et al., 1995), 
adrenomedelluary endothelial cells (Ferrero and Torres, 2001), cardiomyocytes (Taimor et 
al., 2000) and vascular smooth muscle cells (Mulsch et al., 1997; Galle et aL, 1999) in a 
concentration-dependent manner. In addition, YC-1 has been reported to potentiate both 
CO- and NO-induced sGC stimulation (Friebe et al., 1996; Friebe et al., 1998). YC-1 was 
not only shown to activate sGC, but was also shown to stimulate NO synthesis and release 
through stimulating calcium entry in endothelial cells (Wohlfart et al., 1999). YC-1 also 
affected cyclic GMP metabolism by inhibiting several phosphodiesterases that cause 
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cGMP breakdown (Galle et al.，1999). Thus, YC-1 is an effective agent for causing direct 
activation of sGC and prolonged elevations of cGMP levels in mammalian cells. 
Cyclic GMP-dependent protein kinase (protein kinase G or PKG) is thought to be 
the major downstream target of cGMP within mammalian cells (Fiscus, 1988; Fiscus and 
Murad, 1988; Lincoln and Comwell, 1993). Intracellular activation of PKG was first 
shown in vascular smooth muscle cells following their exposure to the cGMP-elevating 
agents NO (Fiscus et al., 1983) and atrial natriuretic peptide (ANP) (Fiscus, 1985)，and 
was proposed to mediate NO- and ANP-induced vasorelaxation. More recently, 
intracellular activation of PKG has been shown in epithelial cells, including bronchial 
epithelial cells, in which PKG appears to mediate increased frequency of ciliary beating 
(Wyatt et al., 1998), and intestinal epithelial cells, in which PKG appears to mediate 
activation of the cystic fibrosis transmembrane conductance regulator CI channel 
(Vaadrager et al., 1998). However, the physiological role of PKG is uterine epithelial cells 
is currently unknown. 
Recently, our laboratory has shown that serum-deprivation causes onset of 
apoptosis and increased levels of DNA fragmentation in an immortalized uterine epithelial 
cell line, the HRE-H9 cells (Fiscus et al , 2001a). Furthermore, we have shown that 
inhibition of basal sGC activity using ODQ or inhibition of basal PKG activity using 
KT5823 causes induction of apoptosis in HRE-H9 cells (Chan and Fiscus, 2002). These 
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data suggest that the basal activities of sGC and PKG are important for preventing a 
spontaneous onset of apoptosis in these cells. However, the effects of elevating the 
intracellular activities of sGC and PKG above basal levels in uterine epithelial cells have 
not been reported until now. 
In the present study, we determined the effects of a direct, NO-independent sGC 
activator, YC-1, on the apoptosis induced by serum deprivation in HRE-H9 cells. NO was 
not used as an activator of sGC in the present study because it is known to activate a 
number of toxic/pro-apoptotic pathways that are independent of the sGC/cGMP pathway 
(Fiscus and Ming, 2000; Fiscus, 2002; Fiscus et al., 2002,). We further determined the 
effects of three cGMP analogues, 8-Br-cGMP, 8-pCPT-cGMP, Sp-8-Bromo-PET-cGMPS, 
all of which are cell-permeable, direct activators of PKG, on the induction of apoptosis in 
HRE-H9 cells. To measure apoptosis, this study used a novel, quantitative, ultrasensitive 
technique recently developed in our laboratory for the accurate measurement of apoptotic 
DNA fragmentation, using capillary electrophoresis with laser-induced fluorescence 
detector (CE-LIF) (Fiscus et al., 2001a, Fiscus et al., 2001b, Cheuk et al., 2002). 
104 
6.3 Results 
Enhancement of Apoptosis by YC-1, a Soluble Guanylyl Cyclase (sGC) Activator, in 
HRE-H9 Cells 
To examine whether activation of sGC and, hence, increases in the cGMP levels 
could modulate the apoptosis of uterine epithelial cells, the HRE-H9 cells were cultured in 
serum-free medium with and without the sGC activator YC-1. Exposure of HRE-H9 cells 
to YC-1 for 24 h caused an increase in DNA fragmentation above that of the control cells 
with serum-deprivation alone, as measured by CE-LIF (Figure 6.1). While YC-1 at 1 |iM 
and 10 nM had no significant effect on cell apoptosis, YC-1 at 100 |LIM significantly 
increased apoptotic DNA fragmentation in HRE-H9 cells (P<0.05; n=4) (Figure 6.2). YC-1 
at 100 [iM caused 5.4- fold increases in DNA fragmentation above controls. 
Effects of the cGMP Analogs 8-Br-cGMP and 8-pCPT-cGMP on Apoptosis in HRE-
H9 Cells with and without Serum-deprived Conditions 
The cGMP analogs 8-Br-cGMP and 8-pCPT-cGMP are commonly used as potent 
and selective activators of PKG (Butt et al., 1992). 8-pCPT-cGMP has been shown to be 
completely resistant to hydrolysis by cGMP-stimulated phosphodiesterase (cGS-PDE, 
PDE2), cGMP-inhibited phosphodiesterase (cGI-PDE, PDE3), Ca^^-calmodulin-dependent 
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phosphodiesterase (CaM-PDE, PDEl) and cGMP-specific cGMP-binding 
phosphodiesterase (cGB-PDE, PDE5). In contrast，8-Br-cGMP was hydrolysed by these 
phosphodiesterases, although at a slower rate than cGMP (Butt et al., 1992). Thus, 8-
pCPT-cGMP would be predicted to be a better and more persistent activator of PKG, 
compared to 8-Br-cGMP, because of its better resistance to hydrolysis within mammalian 
cells. 
Because the sGC activator YC-1 had enhanced the apoptosis in HRE-H9 cells and 
because this pro-apoptotic effect may have been mediated by activation of PKG, we 
further determined if direct activation of PKG by the cell-permeable cGMP analogs could 
also enhance the apoptosis. When 8-Br-cGMP at 100 iiM and 1 mM was added to the 
HRE-H9 cells for 24h there appeared to be small increases in the apoptotic DNA 
fragmentation levels compared to control levels (Figure 6.3). However, these apparent 
effects of 8-Br-cGMP were not statistically significant at the 5% level (Figure 6.4). In 
contrast, 8-pCPT-cGMP (1 mM) significantly enhanced the levels of apoptotic DNA 
fragmentation in HRE-H9 cells in both the presence (Figures 6.5 and 6.6) and absence 
(Figures 6.7 and 6.8) of serum. 8-pCPT-cGMP (1 mM) elevated the levels of apoptosis in 
HRE-H9 cells by 6.8 fold (Figure 6.6) in the presence of serum and by 6.2 fold (Figure 6.8) 
in the absence of serum, compared to the appropriate controls. The data suggested that 
direct activation of PKG had enhanced the activation of a pro-apoptotic pathway in the 
HRE-H9 cells. The lack of a consistent response to 8-Br-cGMP was likely due to the 
hydrolysis of this cGMP analog, thus limiting the length of the PKG activation. 
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We recognized that a potential technical problem with the use of both 8-Br-cGMP 
and 8-pCPT-cGMP was that they are also potent activators of the cyclic nucleotide-gated 
(CNG) cation channels (Wei et al., 1998), which could potentially contribute to the 
induction of apoptosis because of the influx of Ca through the CNG channels. Therefore, 
to avoid this complication, further experiments were conducted using a more recently 
developed cGMP analog, Sp-8-Br-PET-cGMPS, that is known to activate PKG (Butt et al., 
1995) and inhibit (not activate) the CNG channels (Wei et a l , 1996). 
Enhancement of Apoptosis by the PKG Activator/CNG Channel Inhibitor Sp-8-Br-
PET-cGMPS in Serum-deprived HRE-H9 Cells 
Exposure of HRE-H9 cells to Sp-8-Br-PET-cGMPS (1 - 100 |iM) for 24 h caused 
dose-dependent enhancements in the apoptotic DNA fragmentation caused by serum 
deprivation, as measured by CE-LIF (Figure 6.9). Sp-8-Br-PET-cGMPS at 10 and 100 |LIM 
significantly increased the apoptotic DNA fragmentation by 4.9 and 12.6 fold, respectively, 
as compared with the controls (P<0.05; n=5) (Figure 6.10). 
6.4 Discusion 
Previously, data from our laboratory and many other laboratories had shown that 
the cGMP/PKG signaling pathway plays an important role in protecting mammalian neural 
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cells against the development of apoptosis induced by serum deprivation and several other 
forms of cellular stress (for reviews, see Fiscus, 2002, Fiscus et al., 2002). However, the 
role of the cGMP/PKG pathway in the regulation of apoptosis in uterine epithelial cells has 
not been established. Our laboratory has shown that serum deprivation causes apoptosis, 
indicated by increased levels of apoptotic DNA fragmentation, in HRE-H9 uterine 
epithelial cells (Fiscus et al., 2001a). Furthermore, we have shown that basal levels of 
cGMP and basal activity of PKG protected these cells against spontaneous development of 
apoptosis (Chan and Fiscus, 2002), similar to the protective role of basal cGMP/PKG in 
neural cells (Fiscus, 2002). However, until now it has not been reported whether activation 
of the cGMP/PKG pathway (above the basal levels) could further protect uterine epithelial 
cells against the development of apoptosis. 
The present study shows that addition of direct activators of sGC or PKG, which 
would activate the cGMP/PKG pathway above the basal levels, does not protect the HRE-
H9 cells against apoptosis induced by serum deprivation. Instead, addition of the sGC 
activator YC-1 or the PKG activators 8-pCPT-cGMP and Sp-8-Bromo-PET-cGMPS 
significantly enhanced the apoptotic DNA fragmentation induced by serum deprivation. 
Thus, unlike the protective effects of basal cGMP/PKG activity, the activation of the 
cGMP/PKG pathway above basal levels appears to promote, rather than inhibit, apoptosis 
in these immortalized uterine epithelial cells. 
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Similar pro-apoptotic effects caused by activation of sGC or PKG have previously 
been shown in vascular smooth muscle cells (Pollman et al., 1996), cardiac myocytes 
(Taimor et a l , 2000) and colon tumor cells (Thompson et al., 2000). In the case of colon 
tumor cells, the induction of apoptosis by activation of PKG appeared to involve PKG-
mediated phosphorylation of an oncogenic protein, p-catenin, which then results in 
ubiquitination and subsequent proteolysis of p-catenin (Liu et al., 2001) as well as PKG-
mediated phosphorylation of MEKKl with subsequent activation of the pro-apoptotic 
JNKl pathway (Soh et al., 2001). Further experiments with uterine epithelial cells will be 
needed to determine if the pro-apoptotic effects of YC-1, 8-pCPT-cGMP and Sp-8-Br-
PET-cGMPS also involve PKG-mediated phosphorylation of p-catenin and MEKKl. 
In the present study, we found that YC-1 (100 luM) significantly enhances serum-
deprivation-induced apoptotic DNA fragmentation, quantified by a new ultrasensitive 
quantitative technique using the new CE-LIF technology (Fiscus et aL, 2001a, Fiscus et al., 
2001b, Cheuk et al., 2002; Fiscus, 2002, Fiscus et al” 2002). Previously, YC-1 (75 |LIM) 
was shown to induce apoptosis in cardiomyocytes via the cGMP signaling pathway 
(Taimor et al., 2000). Furthermore, YC-1 treatment of colon tumor cells was shown to 
inhibit growth and induce apoptosis at doses that activate guanylate cyclase (Thompson et 
al., 2000). However, the effect of YC-1 in the regulation of apoptosis appears to be 
different in different types of cells. For example, YC-1 exerted anti-apoptotic effects in 
leukemia cells (Flamigni et al., 2001). Furthermore, we have recently found that YC-1 
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protects against apoptosis in a neural cell line, NG108-15 cells (unpublished data). Thus, 
the effects of YC-1 on apoptosis appear to depend on the type of cells. 
The present study shows that 8-cPCT-cGMP, but not 8-Br-cGMP, significantly 
increases the levels of apoptotic DNA fragmentation in HRE-H9 cells. Because 8-Br-
cGMP, but not 8-pCPT-cGMP, is metabolized by phosphodiesterases (Butt et al., 1992), 
the lack of significant pro-apoptotic effects by 8-Br-cGMP is presumably due to the more 
rapid metabolism, and thus shorter action, of 8-Br-cGMP. 8-pCPT-cGMP has also been 
shown to induce apoptosis in cardiac myocytes (Taimor et al., 2000), similar to the 
responses we have found in HRE-H9 uterine epithelial cells. 
In addition to activating PKG (Butt et al , 1995), 8-pCPT-cGMP has also been 
shown to activate CNG cation channels (Wei et al., 1998). Thus, the induction of apoptosis 
by 8-pCPT-cGMP in our study with HRE-H9 cells may have been due to activation of 
either PKG or CNG channels. The activation of CNG channel would be expected to cause 
influx of Ca2+, which could induce a pro-apoptotic response. Therefore, in order to 
discriminate between the two pathways in their potential involvement in the induction of 
apoptosis by 8-pCPT-cGMP in HRE-H9 cells, we further investigated the effect of another 
PKG activator, Sp-8-Bromo-PET-cGMPS, which is a CNG channel blocker rather than 
activator (Wei et al., 1996). We found that Sp-8-Bromo-PET-cGMPS dose-dependently 
enhanced the apoptosis induced by serum deprivation in HRE-H9 cells, causing 4.9- and 
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12.6-fold increases in the levels of apoptotic DNA fragmentation at 10 and 100 |LIM, 
respectively. Thus, the enhancement of serum-deprivation-induced apoptosis caused by the 
cGMP analogs appears to be mediated by PKG activation, rather than activation of CNG 
channels. 
The present data further illustrate the differences in the pro- and anti-apoptotic 
effects of the sGC/cGMP/PKG signaling pathway in different cell types. Whereas the 
present study demonstrates the pro-apoptotic effects of sGC and PKG activators in HRE-
H9 uterine epithelial cells, many other studies have shown anti-apoptotic effects of sGC 
and PKG activators in a number of different types of neural cells (Fiscus et al., 2001b; 
Fiscus, 2002; Fiscus et al., 2002). However, this difference may not be completely 
dependent on the cell type, but may also be due to the relative levels of activation of sGC 
and PKG within the different types of cells. For example, our previous experiments with 
HRE-H9 cells had shown that basal activities of sGC and PKG protected against a 
spontaneous onset of apoptosis (Chan and Fiscus, 2002). The present study shows that 
when the sGC and PKG activities are stimulated above the basal levels, the effect of 
sGC/cGMP/PKG pathway seems to switch from an anti-apoptotic to a pro-apoptotic effect. 
Thus, in uterine epithelial cells the sGC/cGMP/PKG signaling pathway appears to play a 
dual role, i.e. protecting against apoptosis when stimulated at low (basal) levels, but 
inducing apoptosis when stimulated at higher levels. This pro-apoptotic effect of the 
highly-activated sGC/cGMP/PKG pathway may participate in the increased levels of 
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apoptosis of uterine epithelial cells that occur during menstruation and implantation of an 
embryo within the uterine wall, because both events involve an exaggerated production of 
NO that highly activates the sGC/cGMP/PKG pathway (Gouge et al., 1998, Tschugguel et 
al., 1999). 
A recent publication that profiles the expression levels of 14 different protein 
kinases during the neoplastic transformation of human ovarian surface epithelial cells has 
identified PKG as the one protein kinase showing the most dramatic change in expression 
levels during the transformation of these cells from a normal phenotype to a tumorigenic 
phenotype (Wong et al., 2001). PKG expression levels were relatively high in normal 
ovarian epithelial cells, considerably lower in SV40-immortalized non-tumorigenic ovarian 
epithelial cells and undetectable in SV40-immortalized ovarian epithelial cells that had 
been further transformed into tumorigenic cells by the transfection of cadherin. Also, three 
ovarian cancer cell lines were found to have undetectable levels of PKG. Although further 
experiments are needed to precisely determine the role of PKG in these cells，it is tempting 
to speculate that the dramatic loss of PKG is an important part of the transformation and 
tumorigenic process in epithelial cells. Based on the data of the present study, showing 
pro-apoptotic effects of PKG activation in epithelial cells, it would be predicted that a loss 
of PKG expression during transformation may increase the cells resistance to the induction 
of apoptosis, thus contributing to the enhanced survival of the transformed epithelial cells. 
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In conclusion, the activities of sGC and PKG and the levels of cGMP in uterine 
epithelial cells are likely to be strictly regulated and to participate in both anti-apoptotic 
and pro-apoptotic pathways regulating cell survival. Although basal activities of sGC and 
PKG have anti-apoptotic effects, the elevation of the sGC and PKG activities above basal 
levels appears to switch the anti-apoptotic effect to a pro-apoptotic effect. Future studies 
will be needed to determine the precise downstream targets of cGMP and PKG mediating 
these effects in uterine epithelial cells. Because the cGMP/PKG pathway is activated by 
NO, the NO-mediated apoptosis of uterine epithelial cells known to occur during 
menstruation and implantation of the embryo may be mediated, at least in part, via the pro-
apoptotic effects of cGMP/PKG activation. 
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Figure 6.1. YC-1 caused dose-dependent enhancement of the apoptotic DNA 
fragmentation induced by serum deprivation in HRE-H9 cells. The data represent the 
CE-LIF electropherograms of the apoptotic DNA fragments isolated from the HRE-H9 
cells in the different treatment conditions: (A) control cells with serum deprivation, (B) 
cells with both serum deprivation and treatment with 1 |LIM YC-1, (C) cells with both 
serum deprivation and treatment with 10 i^M YC-1, and (D) cells with both serum 
deprivation and treatment with 100 \iM YC-1. In all cases, the serum deprivation and 
exposure to YC-1 lasted for 24 h. Each electropherogram represents a sample from cells 
incubated in serum-free medium in a well of a 6-well culture plate. Samples in all 
electropherograms were from cells of the same passage in the same experiment. This 
electropherogram set is representative of 4 experiments. 
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Figure 6.2. The combined data of 4 experiments showing the dose-dependency of the 
pro-apoptotic effects of YC-1 after 24 h of exposure. The amounts of the 540 bp DNA 
fragment were measured in samples from HRE-H9 cells in the different treatment 
conditions. The data represent the means 土 SEM of n=4 samples per group. *P<0.05, 
comparing the treatment groups to the control. The number on the top of the bar indicates 
the fold increase in the amount of DNA fragmentation compared to control. 
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Figure 6.3. CE-LIF electropherograms of the apoptotic DNA fragments isolated from the 
HRE-H9 cells treated with 8-Br-cGMP. The conditions are: (A) control cells, (B) cells 
treated with 100 ^iM 8-Br-cGMP, and (C) cells treated with 1 mM 8-Br-cGMP. The 
exposure time in each case was 24 h. Each electropherogram represents a sample from 
cells incubated in a well of a 6-well culture plate containing medium supplemented with 
4% fetal bovine serum. Samples in all electropherograms were from cells of the same 
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Figure 6.4. The combined data of 4-6 experiments showing that 8-Br-cGMP 
appears to increase apoptotic DNA fragmentation, but the effects were not 
statistically significant at the 5% level (i.e. P>0.05). The amounts of the 540 bp 
DNA fragment were measured in samples from HRE-H9 cells in the different 
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Figure 6.5. CE-LIF electropherograms of the apoptotic DNA fragments isolated from 
the HRE-H9 cells treated with 8-pCPT-cGMP in the presence of serum. The conditions 
were: (A) control cells, (B) cells treated with 100 |LIM 8-pCPT-cGMP, and (C) cells 
treated with 1 mM 8-pCPT-cGMP. The exposure time in each case was 24 h. Each 
electropherogram represents a sample from cells incubated in a well of a 6-well culture 
plate containing medium with 4 % fetal bovine serum. Samples in all 
electrophero grams were from cells of the same passage in the same experiment. The 
electropherogram set is representative of 6 experiments. 
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Figure 6.6. The combined data of 6 experiments showing the dose-dependency of the 
pro-apoptotic effect of 8-pCPT-cGMP (24 h). The amounts of the 540 bp DNA 
fragment were measured in samples from HRE-H9 cells in the different treatment 
conditions. The data represent the means 土 SEM of n=6 samples per group. *P<0.05, 
comparing the treatment groups to the control. The number on the top of the bar 
indicates the fold-increase in the amount of DNA fragmentation compared to control. 
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Figure 6.7. CE-LIF electropherograms of the apoptotic DNA fragments isolated from 
the HRE-H9 cells treated with 8-pCPT-cGMP under serum-free conditions. The 
conditions are: (A) control cells, (B) cells treated with 100 |LIM 8-pCPT-cGMP, and 
(C) cells treated with 1 mM 8-pCPT-cGMP. The exposure time in each case was 24 h. 
Each electropherogram represents a sample from cells incubated in a well of a 6- well 
culture plate containing medium without serum. Samples in all electropherograms 
were from cells of the same passage in the same experiment. The electropherogram 
set is representative of 5 experiments. 
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Figure 6.8. The combined data of 5 experiments showing the dose-dependency of 
the pro-apoptotic effects of 8-pCPT-cGMP (24 h) under serum-free conditions. The 
amounts of the 540 bp DNA fragment were measured in samples from HRE-H9 
cells in the different treatment conditions. The data represent the means 土 SEM of 
n=5 samples per group. *P<0.05, comparing the treatment groups to the control. 
The number on the top of the bar indicates the fold-increase in the amount of DNA 
fragmentation compared to control. 
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Figure 6.9. CE-LIF electropherograms of the apoptotic DNA fragments isolated 
from the HRE-H9 cells treated with Sp-8-Br-PET-cGMPS. The conditions are: (A) 
control cells, (B) cells treated with 1 [xM Sp-8-Br-PET-cGMPS, (C) cells treated 
with 10 |LIM Sp-8-Br-PET-cGMPS, and (D) cells treated with 100 JIM Sp-8-Br-
PET-cGMPS. All cells were incubated in serum-free media. The exposure time in 
each case was 24 h. Each electropherogram represents a sample from cells in a 
well of a 6-well culture plate. Samples in all electropherograms were from cells of 
the same passage in the same experiment. The electropherogram set is 
representative of 5 experiments. 
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Figure 6.10. The combined data of 5 experiments showing the dose-dependency of 
the pro-apoptotic effects of Sp-8-Br-PET-cGMPS (24 h). The amounts of the 540 bp 
DNA fragment were measured in samples from HRE-H9 cells in the different 
treatment conditions. The data represent the means 土 SEM of n=5 samples per group. 
*P<0.05, comparing the treatment group to the control. ***P<0.001, comparing the 
treatment group to the control. The number on the top of each bar indicates the fold-
increase in the amount of DNA fragmentation compared to control. 
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Chapter 7: ODQ, an inhibitor of soluble guanylyl cyclase, down-regulates XIAP 
expression and induces apoptosis in human ovarian cancer cells 
7.1 Abstract 
Basal activity of soluble guanylate cyclase (sGC) and basal levels of cGMP appear 
to be necessary for the survival of a number of cells, including leukaemia cells, uterine 
epithelial cells as well as certain neural cells. X-linked inhibitor of apoptosis protein 
(XIAP), a member of the inhibitor of apoptosis protein (lAP) family, has been 
demonstrated to suppress apoptosis in human ovarian epithelial cancer cells. Until now, to 
our knowledge, there have been no reports concerning the effects of sGC on the regulation 
of apoptosis and the expression of XIAP in ovarian cancer cells. We hypothesized that 
basal sGC activity is anti-apoptotic in human ovarian cancer cells and that the anti-
apoptotic function of the sGC/cGMP signaling pathway may involve the regulation of 
XIAP expression. In the present study, we determined the effects of the sGC inhibitor 
ODQ on XIAP level and apoptosis in a cisplatin-sensitive ovarian cancer cell line, A2780s 
cells. For comparison, we have also determined the effects of an agonistic monoclonal 
anti-Fas antibody (Fas mAb) on these parameters. To test whether the decrease in XIAP 
content by ODQ had contributed to the induction of apoptosis, we further determined if 
over-expression of XIAP could prevent apoptosis induced by ODQ. Exposure of A2780s 
cells to Fas mAb and ODQ for 24 h caused a concentration-dependent increase in 
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apoptosis, as measured by Hoechst staining. Whereas Fas mAb had no effect on XIAP 
levels, ODQ at 10, 50 and 100 \xM significantly decreased XIAP content and increased the 
percentage of apoptotic cells by 2.3-, 6.0- and 7.8-fold, respectively. Over-expression of 
XIAP attenuated the ODQ-induced apoptosis in a concentration-dependent manner. These 
findings suggest that basal sGC activity and cGMP levels may be involved in preventing 
spontaneous apoptosis in ovarian cancer cells and that the down-regulation of XIAP may 
be an important event in the ODQ-induced apoptosis in A2780s ovarian cancer cells. 
7.2 Introduction 
Ovarian cancer is the most lethal gynaecological cancer in the Western world and 
ranks fifth among the most common female cancers (Wingo et al., 1995). Among all kinds 
of human ovarian malignancies, epithelial ovarian tumours, which originate from the 
surface epithelium of the ovary, account for over 85% (Neyns et al., 1996). 
Tumour growth is now accepted to be the result of an imbalance between cell 
proliferation and apoptosis (Kerr et al, 1994; Levine et al , 1995; Sheets and Yeh, 1997; 
LaCass et aL, 1998). Dysregulated apoptosis may contribute to the pathogenesis of a 
number of diseases, including cancer (Liebermann et al., 1995), autoimmune diseases 
(Reap et al., 1995), and many neurodegenerative disorders, including Alzheimer's disease 
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and Parkinson's disease (Estevez et al., 1998; Fiscus and Ming, 2000; Fiscus, 2002; Fiscus 
et al., 2002). 
Recent research has demonstrated the presence of several potent endogenous 
suppressers of apoptosis, the inhibitor of apoptosis proteins (lAPs), in mammalian cells. 
lAPs were first identified in baculoviruses, where they keep the host cells alive while the 
viruses replicate (Bimbaum et al., 1994; Crook et al., 1993). The lAP family currently 
consist of six members: neuronal apoptosis inhibitory protein [NAIP; Roy et a l , 1995], X-
linked inhibitor of apoptosis protein (XIAP; Listen et al., 1996; Uren et al., 1996; Duckett 
et al., 1996), human inhibitor of apoptosis protein-1 (HIAP-1) (Listen et al., 1996; Uren et 
al., 1996; Duckett et al., 1996), human inhibitor of apoptosis protein-2 (HIAP-2; Liston et 
al., 1996; Uren et al” 1996; Rothe et al., 1995), survivin (Ambrosini et al., 1997) and Livin 
(Kasof and Gomes, 2001). With the exception of NAIP and survivin, which only have the 
N-terminal repeats named baculovirus lAP repeats (BIRs; required for biologic function), 
all the other mammalian lAPs identified to date possess both N-terminal BIRs and a C-
terminal RING-zinc finger domain, which is required for protein-protein interaction. 
The role of XIAP in the regulation of apoptosis in human ovarian cancer has been 
examined recently. XIAP is localized in human ovarian carcinomas, in which there are 
higher levels of XIAP in proliferative epithelial cancer cells compared to apoptotic 
epithelial cancer cells (Li et al., 2000; Li et al, 2001a). The pro-apoptotic agent cisplatin, a 
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chemotherapeutic agent commonly used in the treatment of ovanan cancer, has been 
shown to decrease XIAP content and induce apoptosis (Li et al., 2000; Li et al., 2001a). 
XIAP is known to suppress apoptosis via caspase -3 and -7 inhibition (Deverasaux et al., 
1997; Takahashi et al., 1998) as well as interfering with the Bax/cytochrome c pathway by 
inhibiting caspase-9 (Deveraus et al., 1998, 1999). Over-expression of lAPs has been 
shown to suppress apoptosis in mammalian cells. For example, over-expression of NAIP, 
XIAP, HIAP-1 or HIAP-2 protects Chinese hamster ovary (CHO) and RAT-1 cells from 
apoptosis triggered by menadione (Liston et al., 1996) and over-expression of XIAP or 
HIAP-2 protects HeLa cells from apoptosis induced by transient transfection of pro-
interleukin-1 P-converting enzyme (Uren et al., 1996). Furthermore, the laboratory of 
Professor Benjamin K. Tsang of the University of Ottawa, collaborator on this part of the 
thesis project, has recently shown that over-expression of XIAP in human ovarian 
epithelial cancer cells markedly attenuates cisplatin-induced apopotosis (Asselin et al.， 
2001: Li et al.. 2001a). Although Hiap-2 is present in A2780s cell lines, it content in the 
cell lines was not significantly affected by cisplatin and decreased to a lesser extent than 
Xiap in OY2008, suggesting a less important role for Hiap-2 in ovarian tumor biology. 
Soluble guanylate cyclase (sGC), the enzyme responsible for the synthesis of most 
of the basal cGMP in mammalian cells (入Valdman and Murad, 1987; Garthwaite et a., 1995; 
Fiscus. 2002). has been demonstrated to be necessary for the survival of L1210 leukemia 
cells under normal growing conditions as well as for protection against various apoptotic 
stimuli (Flamigni et al., 2001). Our previous studies have demonstrated that the basal 
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activities of sGC and a downstream target protein in the cGMP signaling pathway, protein 
kinase G (PKG), may be important for the survival of uterine epithelial cells (Chan and 
Fiscus, 2002) and several neural cell lines (Yuen and Fiscus, 2001; Fiscus, 2002). 
Specifically, basal activities of sGC and PKG appear to protect these cells against 
spontaneous apoptosis. We have hypothesized that basal sGC activity and cGMP levels are 
anti-apoptotic in human ovarian cancer cells, and that this effect involves in part the 
regulation of XIAP expression. Until now, to our knowledge, there have been no reports 
concerning the effects of sGC on the regulation of XIAP expression and apoptosis in 
ovarian cancer cells. 
In the present study, we have determined the effects of the sGC inhibitor ODQ on 
XIAP content and apoptosis in the ovarian epithelial cancer cell line A20780s. For 
comparison, we have also determined if an agonistic monoclonal anti-Fas antibody alters 
these parameters. Previous studies in the laboratory of Professor Benjamin K. Tsang had 
shown that the anti-Fas antibody decreased XIAP level and induced apoptosis in another 
ovarian cancer cell line, OV2008 (unpublished data). In the present study, we found that 
ODQ and anti-Fas antibody both significantly increase the levels of apoptosis in A2780s 
cells. However, only ODQ significantly decreased XIAP levels in these cells. Over-
expression of XIAP in A2780s cells completely prevented apoptosis induced by ODQ. 
These findings support the concept that ODQ induces apoptosis through down-regulation 
of XIAP content in ovarian cancer cells. 
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7.3 Results 
Induction of apoptosis, but no change in XIAP levels, by an agonistic Fas mAb in 
A2780S cells 
A2780s cells cultured in the absence of an exogenous agonist exhibited normal cellular 
morphology, as evident by their adherence to the growth surface and flat, cobblestone-like 
appearance. Addition of an agonistic monoclonal anti-Fas antibody (Fas mAb) induced 
apoptotic features, including cell rounding and shrinkage as well as nuclear condensation 
and fragmentation (Figure 7.1 A). The apoptosis induced in the A2780s cells was 
significant at all three concentrations (0.5, 1.0 and 2.0 j^g/ml) of Fas mAb tested (Figure 
7.IB). Fas mAb, at the same concentrations, had no detectable effects on the levels of 
XIAP in the A2780s cells (Figure 7.2) 
Induction of apoptosis by the soluble guanylyl cyclase (sGC) inhibitor ODQ in 
A2780S cells 
Previously, we had shown that ODQ induces apoptosis in an immortalized uterine 
epithelial cell line, the HRE-H9 cells (Chan and Fiscus, 2002), and two established neural 
cell lines (NlE-115 and NG108-15 cells) (Yuen and Fiscus, 2002; Fiscus, 2002), 
suggesting that basal levels of sGC activity are important for preventing spontaneous 
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induction of apoptosis in these cells. To examine whether basal levels of sGC modulate the 
apoptosis of ovarian cancer cells, the A2780s cells were incubated in the presence or 
absence of ODQ, a potent and selective inhibitor of sGC (Garthwaite et aI., 1995; Moro et 
aI., 1996; MU] : 'I .~h et aI., 1997; Olesen et aI., 1998). Our previous studies had shown that 
ODQ at 40 J.lM (24 h exposure) completely inhibited ~GC activity, lowered basal levels of 
cGMP to one-fifth of normal levels and induced apoptosis in two neural cell lines, NG 1 08-
15 cells (Yuen and Fiscus, 2001; Fiscus et ai., 2002) and NIE-115 cells (Fiscus et aI., 
2002). In the present study, we found that exposure of A2780s cells to ODQ (1-100 J.lM) 
for 24 h caused a concentration-dependent increase in apoptosis, as measured by Hoechst 
nuclear staining (Figure 7.3). While ODQ at 1 J.lM had no significant effect on A2780s cell 
apoptosis when compared with the controls, it significantly increased nuclear chromatin 
condensation and fragmentation in the A2780s cells at 10, 50 and 100 J.lM. At these 
concentrations, ODQ caused 2.3-,6.0- and 7.8-fold increases in the percentage of apoptotic 
cells (Figure 7.4) suggesting that adequate basal sGC activity and cGMP levels may be 
important in preventing spontaneous apoptosis in the ovarian cancer cells. 
ODQ down-regulates XIAP expression in A2780s cells 
To determine whether XIAP down-regulation could be associated with the induction of 
apoptosis by ODQ, changes in XIAP content in A2780s cells incubated with ODQ (1-100 
J.lM) for 24 h were assessed by Western blot analysis. ODQ induced morphological 
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changes indicative of apoptosis in some of the A2780s cells as shown in Figure 7.3. The 
increase in the incidence of apoptosis was accompanied by significant concentration-
dependent decreases in XIAP content and to a smaller extent in ~-tubulin content (Figure 
7.SA). GAPDH (.ontent however, was not significantly affected by the ODQ treatment, and 
was thus used to normalize the XIAP levels (Figure 7.SA). Statistical analysis of the 
quantified XIAP protein level in relation to those of GAPDH revealed that ODQ 
significantly reduced XIAP levels in the A2780s cells in a concentration-dependent 
manner (P<O.OOl) and that at 10 J.lM of ODQ, XIAP content was approximately SO% of 
that in the control cells (Figure 7.SB). Thus, at concentrations that induced apoptosis, ODQ 
significantly decreased the content of the anti-apoptotic protein XIAP, suggesting that a 
down-regulation of XIAP level may be a contributing event in ODQ-induced apoptosis in 
these ovarian cancer cells. 
XIAP over-expression prevents ODQ-induced apoptosis in A2780s cells 
To determine whether a decrease in XIAP content was indeed an important determinant in 
ODQ-induced apoptosis in A2780s cells, the influence of XIAP over-expression on the 
ability of ODQ to induce apoptosis in A2780s cells was determined after infection of the 
ovarian cancer cells with adenoviral full-length XIAP sense cDNA. XIAP over-expression 
caused a dose-dependent protection of the A2780s cells against the ODQ-induced 
apoptosis (Figure 7.6) . At MOl = 10, XlAP over-expression completely prevented 
apoptosis induced by ODQ. These data confirm that the XIAP down-regulation may be an 
131 
important element in the ODQ-induced apoptosis in A2780s cells. Figure 7.7 shows that 
ODQ reduced XIAP protein content in A2780s cells infected 48 h earlier with adenoviral 
Lac Z (control vector) but not with adenoviral XIAP sense cDNA. Adenoviral XIAP sense 
infection elevated the XIAP level significantly above the control levels (P<0.001; Figure 
7.7B) 
7.4 Discussion 
The soluble form of guanylyl cyclase (sGC) is a heme-containing enzyme that is 
activated by the binding of nitric oxide (NO) to the heme moiety (Waldman and Murad, 
1987). Beauvais and coworkers have shown that activation of sGC by NO donors and the 
subsequent elevation of cGMP levels result in an inhibition of the apoptosis induced by 
cytokine deprivation in eosinophils (Beauvais et al., 1995). Since this early report, several 
other types of cells, most notably neural cells, have been shown to be protected against 
induction of apoptosis when cGMP levels are elevated by the activation of either sGC or 
particulate guanylyl cyclase (Kim et al , 1999; Fiscus et al., 2001b; Fiscus, 2002; Fiscus et 
al., 2002). 
Even in the absence of NO, sGC has basal activity, contributing to most of the 
basal cGMP levels found in mammalian cells (Waldman and Murad, 1987; Garthwaite et 
al. 1995; Fiscus, 2002). Inhibition of this basal sGC activity, using specific sGC inhibitors 
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like ODQ, can result in the lowing of the basal levels of cGMP (Garthwaite et al., 1995; 
Flamigni et al., 2001; Fiscus, 2002). Several recent studies have suggested that basal sGC 
activity and basal cGMP levels may be sufficient to activate, at least partially, the cGMP-
mediated anti-apoptotic/pro-survival pathway in certain mammalian cells, thus protecting 
these cells against spontaneous apoptosis. For example, inhibition of sGC by ODQ was 
found to induce marked increases in caspase activity, which was associated with a loss of 
cell viability and a reduction in cGMP content in L1210 leukemia cells (Flamigni et al., 
2001). Furthermore, ODQ provoked the processing of caspase-3 and -9, release of 
cytochrome c，reduction of Bcl-2 content and dephosphorylation of Bad at Ser 112 in the 
L1210 leukaemia cells. Thus, ODQ and the inhibition of sGC appear to alter a number of 
apoptosis-regulating pathways, ultimately resulting in the induction of apoptosis in the 
leukaemia cells. These data suggest that the basal activity of sGC is essential in preventing 
a spontaneous activation of pro-apoptotic pathways, at least in leukemia cells. Our recent 
studies have demonstrated that the basal activities ofsGC and a downstream target protein 
in the cGMP signaling pathway, protein kinase G (PKG), may be important for the 
survival of two other types of cells, an immortalized uterine epithelial cell line (Chan and 
Fiscus, 2002) and two established neural cell lines (Yuen and Fiscus, 2001; Fiscus, 2002). 
Specifically, we have found that basal activities of sGC and PKG are necessary to protect 
these cells against a spontaneous induction of apoptosis under normal growing conditions. 
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The laboratory of Professor Benjamin K. Tsang has previously shown that addition 
ofcisplatin to human ovarian surface epithelial cancer cell cultures decreases XIAP protein 
content and induces apoptosis in cisplatin-sensitive ovarian cancer cells (Li et al., 2000a; 
Li et al., 2001a). Over-expression of XIAP in these cells by adenoviral sense XIAP cDNA 
infection effectively attenuates cisplatin-induced apoptosis (Li et al” 2001a). In the present 
study, we hypothesized that basal sGC activity and basal levels of cGMP may cause anti-
apoptotic effects in human ovarian cancer cells and that this effect may involve the 
regulation of XIAP expression. Until now, to our knowledge, there have been no reports 
concerning the effects of sGC on apoptosis as well as on the regulation of the expression of 
XIAP in ovarian cancer cells. In the present study, we determined the effects of the sGC 
inhibitor ODQ on the regulation of XIAP content and apoptosis in the cisplatin-sensitive 
ovarian cancer cell line A2780s. The present study also tested the effects of an agonistic 
Fas monoclonal antibody (Fas mAb) on XIAP level and apoptosis in the cells. Previously, 
we had found that Fas mAb induces apoptosis (Schneiderman et al., 1999) and down-
regulates XIAP expression (unpublished data) in another cisplatin-sensitive ovarian cancer 
cell line. 
In the present study, an agonistic Fas mAb significantly induced apoptosis in 
A2780S cells in a concentration-dependent manner, as evident by the presence of cellular 
condensation, nuclear fragmentation and apoptotic bodies, but did not down-regulate the 
XIAP level. In contrast, ODQ concentration-dependently decreased the XIAP content and 
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induced apoptosis in A2780s cells. The findings suggest that the basal sGC activity is 
essential to protect the A2780s cells against a spontaneous apoptosis, as previously shown 
in uterine epithelial cells (Chan and Fiscus, 2002) and neural cells (Yuen and Fiscus, 2001; 
Fiscus, 2002). Furthermore, because the increase in apoptosis was accompanied by a 
decrease in XIAP content, we suspected that the ODQ-induced apoptosis in the A2780s 
cells had resulted, at least in part, from a decrease in XIAP content and thus the subsequent 
loss of an anti-apoptotic mechanism within the cell. The precise mechanism of the ODQ-
induced decrease in XIAP content in A2780s cells is currently not known. In addition to 
suppressed gene expression, it is possible that the decreased XIAP content could be a 
consequence of increased XIAP ubiquitination / proteosome degradation (Yang et al 2000) 
or caspase-3-mediated processing (Deveraux et al 1999). Nonetheless, the present data 
suggest that basal sGC activity and basal levels of cGMP may be necessary for the 
maintenance of a sufficiently high level of XIAP in the cisplatin-sensitive human ovarian 
cancer cells to ensure cell survival and growth under normal conditions. 
To further confirm the contribution of XIAP down-regulation in the ODQ-induced 
apoptosis, we determined if XIAP over-expression could prevent the apoptosis induced by 
ODQ. XIAP over-expression by adenoviral infection with sense XIAP cDNA resulted in 
dose-dependent protection, and at the highest level of over-expression complete protection, 
of the A2780S cells from the ODQ-induced apoptosis. These data thus add further support 
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for the concept that ODQ, via inhibition of sGC and lowering of basal cGMP levels, 
induces apoptosis, at least in part, by down-regulating XIAP level in ovarian cancer cells. 
The mechanisms by which XIAP exert its anti-apoptotic effects are still not fully 
understood. The lAPs have been shown to directly inhibit certain cell-death proteases, such 
as caspase-3, caspase-7 (Daveraux et al” 1997; Roy et a l , 1997; Takahashi et al., 1998) 
and caspase-9 (Deveraux et a l , 1999). Furthermore, XIAP expression levels appear to 
regulate the activation of caspases-3 and caspases-9. For example, the laboratory of 
Professor Benjamin K. Tsang has shown that XIAP down-regulation following antisense 
infection in A2780s cells causes caspases-3 activation (Sasaki et al., 2000). Over-
expression of XIAP blocks the cisplatin-induced cleavage of caspases-9 and caspases-3 in 
A2780S cells (Asselin et al., 2001). Thus, the induction of apoptosis in A2780s cells by 
ODQ in the present study may have resulted from the lowering of XIAP content, which 
would be expected to activate caspases as well as cause a loss of endogenous inhibition of 
caspase activities. If a similar mechanism is present in leukaemia cells, this proposed 
action of ODQ on the down-regulation of XIAP expression may have also contributed to 
the ODQ-induced activation of caspases and onset of apoptosis observed in L1210 
leukaemia cells (Flamigni et al., 2001). Additional studies will be needed to establish 
whether caspase-3 or other cell-death proteases are involved in the ODQ-induced apoptosis 
in ovarian cancer cells. 
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In summary, we have shown that the sGC inhibitor ODQ down-regulates XIAP 
content and induces apoptosis in the human ovarian cancer cell line A2780s. Preventing 
the decrease in XIAP content by over-expressing this protein completely protected the 
cells against ODQ-induced apoptosis. Our findings suggest that basal sGC activity and 
cGMP level may be necessary for the maintenance of high XIAP level for prevention of 
spontaneous apoptosis in these ovarian cancer cells under normal culture conditions. These 
findings provide a new concept for the regulation of apoptosis in ovarian cancer cells and 
of ovarian tumor growth, showing a potential link between the anti-apoptotic effects of the 
sGC/cGMP signaling pathway and the cell survival role of XIAP. 
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Figure 7.1. (A) Representative photomicrograph showing apoptotic nuclear 
morphology (Hoechst staining) in the A2780s ovarian epithelial cancer cells after 
treatment for 24 h with an agonistic Fas mAb (2 |ig/ml). The white arrows indicate 
nuclear fragmentation. Magnification: 400X. (B) Effect of Fas mAb, at selected 
concentrations, on the levels of apoptosis in A2780s cells. The cells were plated at a 
density of 5 x cells/cm^ in 6-well plates and incubated for 24 h in DMEM-F12-
10% FBS followed by incubation for an additional 24 h in serum-free DMEM-F12 
with different concentrations of Fas mAb (0, 0.5, 1 and 2 jig/ml). The data represent 
the means 士 SEM of n=3 samples per group. ***P<0.001, comparing the treatment 
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Figure 7.2. Effect of Fas mAb, at the same concentrations that had resulted in increased 
levels of apoptosis, on XIAP protein content in A2780s cells，assessed by Western blot 
analysis. The Fas mAb has no detectible effect on XIAP protein content. The data are 
representative of three independent experiments. 
139 
• • • • 
Figure 7.3. Representative photomicrographs showing apoptotic nuclear morphology 
(Hoechst staining) in A2780s cells after treatment for 24 h with the sGC inhibitor 
ODQ. Cells were plated at a density of 5 x cells/cm^ in 6-well plates, incubated 
for 24 h in DMEM-F12-10% FBS and further incubated for an additional 24 h in 
serum-free DMEM-F12 with ODQ (0, 1, 10, 50 and 100 ^iM). (A) Cells treated with 0 
ODQ (Control) (400X). (B) Cells treated with 1 |iM ODQ (400X). (C) Cells 
treated with 10 |iM ODQ (400X). (D) Cells treated with 50 jiiM ODQ (400X). (E) 
Cells treated with 100 |iM ODQ (400X). (F) Cells treated with 100 juM ODQ (200X). 
White arrows indicate nuclear fragmentation. 
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Figure 7 4. Effect of ODQ at different concentrations on apoptosis in A2780s cells. Cells 
were treated with ODQ and collected for Hoechst staining, as in Figure 7.3. The percentage 
of cells with apoptotic nuclear morphology are indicated (combined data of five 
experiments). The data represent the means 土 SEM of n=3-5 samples per group. *P<0.05 
and ***P < 0.001，comparing the treatment groups to the control. 
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Figure 7.5. Effect of ODQ at different concentrations on XIAP protein content in 
A2780s cells, assessed by Western blot analysis. (A) Representative blot of the effects of 
ODQ on XIAP, p-tubulin and GAPDH protein contents. (B) Changes in XIAP protein 
content, analysed densitometrically using a Molecular Dynamic Phosphoimager. Data 
represent mean 土 SEM of five experients. ***P<0.001 (compared to control). 
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Figure 7.6. Effect of over-expression of XIAP on ODQ-induced apoptosis in A2780s. 
Cells were plated at a density of 5 x 10^ cells/cm^ in 6-well plates for 24 h in DMEM-
F12-10% FBS and cultured for 48 h without virus or with adenoviral sense XIAP or 
Lac Z (MOI=2.5, 5 or 10) vectors, as described in “Materials and Methods". Cells were 
then treated for 24 h with ODQ (100 |iM) and collected for Hoechst staining (for 
counting the number of apoptotic cells). The graph shows the combined data of three 
experiments, indicating the dose-dependency of the anti-apoptotic effects of XIAP 
over-expression on the ODQ-induced apoptosis in the A2780s cells. The data represent 
the mean 土 SEM o f n = 3 samples per group. *P<0.05 and ***P < 0.001, comparing the 
treatment groups to the control. ++P<0.01, comparing the treatment group to the ODQ 
(100 |iM)-treated (with no viral infection) group. 
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Figure 7.7. Western blot analyses confirming the increases of XIAP protein 
content in A2780s cells treated with adenoviral sense XIAP or Lac Z infection. 
(A) Representative blot showing the effect of over-expressing XIAP on the 
ODQ-induced decreases in XIAP protein contents. (B) Graph indicating the 
changes in XIAP protein content, analysed densitometrically using a Molecular 
Dynamic Phosphoimager. The data represent mean 土 SEM of three experiments. 
*P<0.05 and ***P<0.001 (compared to cells treated with 100 jiiM ODQ but no 
viral infection). 
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Chapter 8: Overall conclusions 
The present study has shown that exogenous NO, provided by the NO donor SNP, 
serum deprivation and overcrowded culturing conditions all cause increases in apoptotic 
DNA fragmentation in uterine epithelial cells, measured by the new quantitative 
ultrasensitive CE-LIF technique. Using this new technique allowed not only accurate 
quantification of the apoptotic DNA fragmentation in rabbit immortalized uterine epithelial 
cells, HRE-H9 cells, but also allowed for the first time quantification of apoptotic DNA 
fragmentation in a limited number of cells in the primary cultures of mouse uterine 
epithelial cells. 
This new ultrasensitive CE-LIF technique was then used to determine the role of 
the sGC/cGMP/PKG signaling pathway in the regulation of apoptosis in uterine epithelial 
cells. The sGC inhibitors NS2028 and ODQ were used to determine the involvement of 
basal sGC activity and basal levels of cGMP in the regulation of apoptosis. The PKG 
inhibitor KT5823 was used to determine the involvement of basal PKG activity in the 
regulation of apoptosis. A non-NO-dependent activator of sGC, YC-1, and direct PKG 
activators, 8-Br-cGMP, 8-pCPT-cGMP and Sp-8-Br-PET-cGMPS, were used to determine 
the effects on apoptosis of activating the sGC/cGMP/PKG signaling pathway above basal 
levels. 
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The present study has shown that NS2028, ODQ, and KT5823, all cause induction 
of apoptotic DNA fragmentation in the uterine epitheial cells, HRE-H9 cells. The data 
suggested that basal levels of sGC and PKG activity are essential to prevent spontaneous 
development of apoptosis in HRE-H9 cells. Since the addition of the cGMP analog 8-Br-
C G M P can prevent the apoptosis induced by ODQ in these cells, the cGMP/PKG siganlling 
pathways appears to play an important role in the regulation of apoptosis in these 
immortalized uterine epithelial cells. 
After showing that basal levels of cGMP and basal activity of PKG protected 
uterine epithelial cells against spontaneous development of apoptosis, further experiments 
were conducted to determine whether activation of the cGMP/PKG pathway above the 
basal levels could further protect uterine epithelial cells against the development of 
apoptosis. Addition of direct activators of sGC or PKG, which would activate the 
cGMP/PKG pathway above the basal levels, did not protect the HRE-H9 cells against 
apoptosis induced by serum deprivation. Instead, addition of the sGC activator YC-1 or the 
PKG activators 8-pCPT-cGMP and Sp-8-Bromo-PET-cGMPS significantly enhanced the 
apoptotic DNA fragmentation induced by serum deprivation. Thus, unlike the protective 
effects of basal cGMP/PKG activity, the activation of the cGMP/PKG pathway above 
basal levels appears to promote, rather than inhibit, apoptosis in these immortalized uterine 
epithelial cells. 
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The activities of sGC and PKG and the levels of cGMP in uterine epithelial cells 
are likely to be strictly regulated and to participate in both anti-apoptotic and pro-apoptotic 
pathways regulating cell survival. Although basal activities of sGC and PKG have anti-
apoptotic effects, the elevation of the sGC and PKG activities above basal levels appears to 
switch the anti-apoptotic effect to a pro-apoptotic effect. Because of the importance of 
uterine epithelial apoptosis in normal menstruation and fertility and in the pathogenesis of 
endometriosis, the effect of the cGMP/PKG pathway in the regulation of apoptosis 
described in the present study may have special importance in the regulation of a number 
of female reproductive functions. 
In addition to uterine epithelial cells, human ovarian cancer cells were also studied 
as a cell culture model to determine the role of basal activity of sGC in the regulation of 
apoptosis. The effects of the sGC/cGMP-signaling pathway in the regulation of XIAP 
expression, which has been demonstrated to suppress apoptosis in these cells, were also 
determined. The resulting data have shown that the sGC inhibitor ODQ down-regulates 
XIAP content and induces apoptosis in the human ovarian cancer cell line A2780s. 
Preventing the decrease in XIAP content by over-expressing this protein completely 
protected the cells against ODQ-induced apoptosis. Our finding suggest that basal sGC 
activity and cGMP levels may be necessary for the maintenance of high XIAP level for 
prevention of spontaneous apoptosis in these ovarian cancer cells under normal culture 
conditions. Also, these findings provide a new concept for the regulation of apoptosis in 
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ovarian cancer cells and of ovarian tumor growth, showing a potential link between the 
anti-apoptic effects of the sGC/cGMP signaling pathway and the cell survival role of XIAP. 
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